ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||
G-protein coupled receptor signaling pathway
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
|
IMP | 9 | 107,543,283 | 107,690,527 | RGD:2290271 | BHF-UCL | ||
| G | ADORA2B | adenosine A2b receptor |
|
TAS | 17 | 15,848,231 | 15,879,210 | RGD:2290271 | PINC | ||
| G | ADRA1A | adrenoceptor alpha 1A |
|
TAS | 8 | 26,605,667 | 26,722,922 | RGD:2290271 | PINC | ||
| G | ADRA1B | adrenoceptor alpha 1B |
|
TAS | 5 | 159,343,740 | 159,400,017 | RGD:2290271 | PINC | ||
| G | ADRA1D | adrenoceptor alpha 1D |
|
TAS | 20 | 4,201,278 | 4,229,659 | RGD:2290271 | PINC | ||
| G | ADRA2A | adrenoceptor alpha 2A |
|
ISS | 10 | 112,836,790 | 112,840,665 | RGD:2290271 | BHF-UCL | ||
| G | ADRA2B | adrenoceptor alpha 2B |
|
TAS | 2 | 96,778,623 | 96,781,888 | RGD:2290271 | PINC | ||
| G | ADRA2C | adrenoceptor alpha 2C |
|
TAS | 4 | 3,768,296 | 3,770,253 | RGD:2290271 | PINC | ||
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
IDA | 1 | 230,838,269 | 230,850,336 | RGD:2290271 | BHF-UCL | ||
| G | AGTR1 | angiotensin II receptor, type 1 |
|
IDA | 3 | 148,415,658 | 148,460,790 | RGD:2290271 | BHF-UCL | ||
| G | AGTR2 | angiotensin II receptor, type 2 |
|
IC | X | 115,301,958 | 115,306,225 | RGD:2290271 | BHF-UCL | ||
| G | AKAP12 | A kinase (PRKA) anchor protein 12 |
|
TAS | 6 | 151,561,134 | 151,679,694 | RGD:2290271 | PINC | ||
| G | AKR1C2 | aldo-keto reductase family 1, member C2 |
|
IDA | 10 | 5,029,967 | 5,060,225 | RGD:2290271 | UniProtKB | ||
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
IDA | 10 | 5,090,958 | 5,149,878 | RGD:2290271 | UniProtKB | ||
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
TAS | 14 | 105,235,686 | 105,262,080 | RGD:2290271 | PINC | ||
| G | APLNR | apelin receptor |
|
TAS | 11 | 57,001,051 | 57,004,927 | RGD:2290271 | PINC | ||
| G | APLP2 | amyloid beta (A4) precursor-like protein 2 |
|
NAS | 11 | 129,939,716 | 130,014,706 | RGD:2290271 | UniProtKB | ||
| G | APOA1 | apolipoprotein A-I |
|
IDA | 11 | 116,706,469 | 116,708,338 | RGD:2290271 | BHF-UCL | ||
| G | APOC3 | apolipoprotein C-III |
|
IDA | 11 | 116,700,624 | 116,703,787 | RGD:2290271 | BHF-UCL | ||
| G | APOE | apolipoprotein E |
|
IDA | 19 | 45,409,039 | 45,412,650 | RGD:2290271 | BHF-UCL | ||
| G | AREG | amphiregulin |
|
IDA | 4 | 75,310,853 | 75,320,726 | RGD:2290271 | BHF-UCL | ||
| G | AREGB | amphiregulin B |
|
IDA | 4 | 75,480,839 | 75,490,481 | RGD:2290271 | BHF-UCL | ||
| G | ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 |
|
TAS | 1 | 156,904,632 | 157,015,162 | RGD:2290271 | UniProtKB | ||
| G | ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 |
|
IDA | 1 | 156,904,632 | 157,015,162 | RGD:2290271 | MGI | ||
| G | ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 |
|
IDA | 11 | 120,207,618 | 120,360,645 | RGD:2290271 | MGI | ||
| G | ATRNL1 | attractin-like 1 |
|
IEA | 10 | 116,853,124 | 117,708,496 | RGD:2290271 | ENSEMBL | ||
| G | AVPR1A | arginine vasopressin receptor 1A |
|
TAS | 12 | 63,536,539 | 63,546,590 | RGD:2290271 | PINC | ||
| G | AVPR1B | arginine vasopressin receptor 1B |
|
TAS | 1 | 206,224,283 | 206,231,482 | RGD:2290271 | PINC | ||
| G | BAI1 | brain-specific angiogenesis inhibitor 1 |
|
TAS | 8 | 143,545,377 | 143,626,368 | RGD:2290271 | GDB | ||
| G | BAI2 | brain-specific angiogenesis inhibitor 2 |
|
TAS | 1 | 32,192,718 | 32,229,648 | RGD:2290271 | GDB | ||
| G | BAI3 | brain-specific angiogenesis inhibitor 3 |
|
TAS | 6 | 69,345,632 | 70,099,403 | RGD:2290271 | GDB | ||
| G | BAIAP3 | BAI1-associated protein 3 |
|
IPI | 16 | 1,383,606 | 1,399,442 | RGD:2290271 | MGI | ||
| G | BCAR1 | breast cancer anti-estrogen resistance 1 |
|
ISS | 16 | 75,262,928 | 75,301,951 | RGD:2290271 | UniProtKB | ||
| G | BCAR1 | breast cancer anti-estrogen resistance 1 |
|
NAS | 16 | 75,262,928 | 75,301,951 | RGD:2290271 | UniProtKB | ||
| G | BCAR1 | breast cancer anti-estrogen resistance 1 |
|
IEA | 16 | 75,262,928 | 75,301,951 | RGD:2290271 | ENSEMBL | ||
| G | BDKRB2 | bradykinin receptor B2 |
|
TAS | 14 | 96,671,135 | 96,710,666 | RGD:2290271 | PINC | ||
| G | BHLHA15 | basic helix-loop-helix family, member a15 |
|
IEA | 7 | 97,841,566 | 97,842,271 | RGD:2290271 | ENSEMBL | ||
| G | C3 | complement component 3 |
|
TAS | 19 | 6,677,846 | 6,720,662 | RGD:2290271 | PINC | ||
| G | C3AR1 | complement component 3a receptor 1 |
|
TAS | 12 | 8,210,919 | 8,218,955 | RGD:2290271 | PINC | ||
| G | C5 | complement component 5 |
|
TAS | 9 | 123,714,613 | 123,812,554 | RGD:2290271 | PINC | ||
| G | CALM1 | calmodulin 1 (phosphorylase kinase, delta) |
|
TAS | 14 | 90,863,327 | 90,874,619 | RGD:2290271 | UniProtKB | ||
| G | CALM2 | calmodulin 2 (phosphorylase kinase, delta) |
|
TAS | 2 | 47,387,221 | 47,403,740 | RGD:2290271 | UniProtKB | ||
| G | CALM3 | calmodulin 3 (phosphorylase kinase, delta) |
|
TAS | 19 | 47,104,512 | 47,114,039 | RGD:2290271 | UniProtKB | ||
| G | CARTPT | CART prepropeptide |
|
ISS | 5 | 71,014,990 | 71,016,875 | RGD:2290271 | HGNC | ||
| G | CASR | calcium-sensing receptor |
|
TAS | 3 | 121,902,530 | 122,005,344 | RGD:2290271 | PINC | ||
| G | CCBP2 | chemokine binding protein 2 |
|
TAS | 3 | 42,850,964 | 42,908,775 | RGD:2290271 | PINC | ||
| G | CCL17 | chemokine (C-C motif) ligand 17 |
|
TAS | 16 | 57,438,679 | 57,449,974 | RGD:2290271 | PINC | ||
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
TAS | 17 | 32,582,296 | 32,584,222 | RGD:2290271 | PINC | ||
| G | CCL23 | chemokine (C-C motif) ligand 23 |
|
TAS | 17 | 34,340,097 | 34,345,005 | RGD:2290271 | PINC | ||
| G | CCL25 | chemokine (C-C motif) ligand 25 |
|
TAS | 19 | 8,117,646 | 8,127,547 | RGD:2290271 | PINC | ||
| G | CCR10 | chemokine (C-C motif) receptor 10 |
|
TAS | 17 | 40,831,420 | 40,833,845 | RGD:2290271 | PINC | ||
| G | CCR5 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
|
IMP | 3 | 46,411,633 | 46,417,697 | RGD:2290271 | UniProtKB | ||
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
TAS | 17 | 38,710,021 | 38,721,736 | RGD:2290271 | BHF-UCL | ||
| G | CCR8 | chemokine (C-C motif) receptor 8 |
|
TAS | 3 | 39,371,197 | 39,375,171 | RGD:2290271 | PINC | ||
| G | CCR9 | chemokine (C-C motif) receptor 9 |
|
TAS | 3 | 45,927,996 | 45,944,667 | RGD:2290271 | PINC | ||
| G | CCRL1 | chemokine (C-C motif) receptor-like 1 |
|
TAS | 3 | 132,316,094 | 132,321,382 | RGD:2290271 | PINC | ||
| G | CCRL2 | chemokine (C-C motif) receptor-like 2 |
|
TAS | 3 | 46,448,721 | 46,451,014 | RGD:2290271 | PINC | ||
| G | CD3E | CD3e molecule, epsilon (CD3-TCR complex) |
|
TAS | 11 | 118,175,295 | 118,186,890 | RGD:2290271 | PINC | ||
| G | CD97 | CD97 molecule |
|
TAS | 19 | 14,491,956 | 14,519,537 | RGD:2290271 | PINC | ||
| G | CELSR1 | cadherin, EGF LAG seven-pass G-type receptor 1 |
|
NAS | 22 | 46,756,731 | 46,933,067 | RGD:2290271 | UniProtKB | ||
| G | CELSR2 | cadherin, EGF LAG seven-pass G-type receptor 2 |
|
NAS | 1 | 109,792,641 | 109,818,378 | RGD:2290271 | UniProtKB | ||
| G | CELSR3 | cadherin, EGF LAG seven-pass G-type receptor 3 |
|
TAS | 3 | 48,673,896 | 48,700,348 | RGD:2290271 | GDB | ||
| G | CHRM1 | cholinergic receptor, muscarinic 1 |
|
TAS | 11 | 62,676,151 | 62,689,012 | RGD:2290271 | PINC | ||
| G | CHRM2 | cholinergic receptor, muscarinic 2 |
|
TAS | 7 | 136,553,399 | 136,701,771 | RGD:2290271 | PINC | ||
| G | CHRM3 | cholinergic receptor, muscarinic 3 |
|
TAS | 1 | 239,792,373 | 240,072,720 | RGD:2290271 | PINC | ||
| G | CMKLR1 | chemokine-like receptor 1 |
|
IDA | 12 | 108,681,821 | 108,733,094 | RGD:2290271 | UniProtKB | ||
| G | CMKLR1 | chemokine-like receptor 1 |
|
NAS | 12 | 108,681,821 | 108,733,094 | RGD:2290271 | UniProtKB | ||
| G | CRHR1 | corticotropin releasing hormone receptor 1 |
|
TAS | 17 | 43,697,710 | 43,913,194 | RGD:2290271 | PINC | ||
| G | CX3CR1 | chemokine (C-X3-C motif) receptor 1 |
|
TAS | 3 | 39,304,985 | 39,323,226 | RGD:2290271 | PINC | ||
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
TAS | 4 | 74,735,109 | 74,737,019 | RGD:2290271 | PINC | ||
| G | CXCL12 | chemokine (C-X-C motif) ligand 12 |
|
TAS | 10 | 44,865,605 | 44,880,545 | RGD:2290271 | PINC | ||
| G | CXCL9 | chemokine (C-X-C motif) ligand 9 |
|
TAS | 4 | 76,922,623 | 76,928,641 | RGD:2290271 | PINC | ||
| G | CXCR1 | chemokine (C-X-C motif) receptor 1 |
|
TAS | 2 | 219,027,568 | 219,031,716 | RGD:2290271 | PINC | ||
| G | CXCR4 | chemokine (C-X-C motif) receptor 4 |
|
IDA | 2 | 136,871,919 | 136,875,725 | RGD:2290271 | UniProtKB | ||
| G | CXCR5 | chemokine (C-X-C motif) receptor 5 |
|
TAS | 11 | 118,754,475 | 118,766,980 | RGD:2290271 | PINC | ||
| G | CXCR6 | chemokine (C-X-C motif) receptor 6 |
|
TAS | 3 | 45,984,973 | 45,989,845 | RGD:2290271 | PINC | ||
| G | DEFB1 | defensin, beta 1 |
|
TAS | 8 | 6,728,097 | 6,735,529 | RGD:2290271 | PINC | ||
| G | DEFB4A | defensin, beta 4A |
|
TAS | 8 | 7,752,199 | 7,754,237 | RGD:2290271 | PINC | ||
| G | DEFB4B | defensin, beta 4B |
|
TAS | 8 | 7,272,385 | 7,274,354 | RGD:2290271 | PINC | ||
| G | DGKQ | diacylglycerol kinase, theta 110kDa |
|
IMP | 4 | 952,672 | 967,348 | RGD:2290271 | UniProtKB | ||
| G | DRD3 | dopamine receptor D3 |
|
IDA | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | BHF-UCL | ||
| G | EDN1 | endothelin 1 |
|
IDA | 6 | 12,290,529 | 12,297,427 | RGD:2290271 | BHF-UCL | ||
| G | EDNRA | endothelin receptor type A |
|
NAS | 4 | 148,402,069 | 148,466,106 | RGD:2290271 | UniProtKB | ||
| G | ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 |
|
TAS | 1 | 79,355,449 | 79,472,495 | RGD:2290271 | GDB | ||
| G | EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 |
|
TAS | 19 | 6,887,560 | 6,940,464 | RGD:2290271 | PINC | ||
| G | EMR2 | egf-like module containing, mucin-like, hormone receptor-like 2 |
|
TAS | 19 | 14,843,509 | 14,889,353 | RGD:2290271 | GDB | ||
| G | EMR3 | egf-like module containing, mucin-like, hormone receptor-like 3 |
|
TAS | 19 | 14,730,051 | 14,785,730 | RGD:2290271 | GDB | ||
| G | EMR4P | egf-like module containing, mucin-like, hormone receptor-like 4 pseudogene |
|
TAS | 19 | 6,952,511 | 6,990,857 | RGD:2290271 | GDB | ||
| G | ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
TAS | 8 | 120,569,317 | 120,651,106 | RGD:2290271 | PINC | ||
| G | ENTPD2 | ectonucleoside triphosphate diphosphohydrolase 2 |
|
IEA | 9 | 139,942,550 | 139,948,503 | RGD:2290271 | ENSEMBL | ||
| G | F2R | coagulation factor II (thrombin) receptor |
|
ISS | 5 | 76,011,868 | 76,031,595 | RGD:2290271 | UniProtKB | ||
| G | F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
|
TAS | 5 | 76,114,833 | 76,131,140 | RGD:2290271 | PINC | ||
| G | FFAR1 | free fatty acid receptor 1 |
|
TAS | 19 | 35,842,445 | 35,843,367 | RGD:2290271 | PINC | ||
| G | FFAR2 | free fatty acid receptor 2 |
|
TAS | 19 | 35,940,617 | 35,942,669 | RGD:2290271 | PINC | ||
| G | FFAR3 | free fatty acid receptor 3 |
|
TAS | 19 | 35,849,488 | 35,851,391 | RGD:2290271 | PINC | ||
| G | FPR1 | formyl peptide receptor 1 |
|
TAS | 19 | 52,249,023 | 52,255,150 | RGD:2290271 | PINC | ||
| G | FPR2 | formyl peptide receptor 2 |
|
TAS | 19 | 52,264,453 | 52,273,779 | RGD:2290271 | PINC | ||
| G | FRS2 | fibroblast growth factor receptor substrate 2 |
|
TAS | 12 | 69,864,129 | 69,973,562 | RGD:2290271 | UniProtKB | ||
| G | FSHR | follicle stimulating hormone receptor |
|
TAS | 2 | 49,189,296 | 49,381,666 | RGD:2290271 | PINC | ||
| G | GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 |
|
TAS | 9 | 101,050,364 | 101,471,479 | RGD:2290271 | PINC | ||
| G | GAST | gastrin |
|
IEA | 17 | 39,868,578 | 39,872,221 | RGD:2290271 | ENSEMBL | ||
| G | GCG | glucagon |
|
TAS | 2 | 162,999,379 | 163,008,914 | RGD:2290271 | PINC | ||
| G | GHRHR | growth hormone releasing hormone receptor |
|
NAS | 7 | 31,003,636 | 31,019,146 | RGD:2290271 | UniProtKB | ||
| G | GHRL | ghrelin/obestatin prepropeptide |
|
ISS | 3 | 10,327,434 | 10,334,631 | RGD:2290271 | UniProtKB | ||
| G | GHRL | ghrelin/obestatin prepropeptide |
|
TAS | 3 | 10,327,434 | 10,334,631 | RGD:2290271 | HGNC | ||
| G | GHRL | ghrelin/obestatin prepropeptide |
|
IEA | 3 | 10,327,434 | 10,334,631 | RGD:2290271 | ENSEMBL | ||
| G | GHSR | growth hormone secretagogue receptor |
|
IDA | 3 | 172,161,081 | 172,166,246 | RGD:2290271 | HGNC | ||
| G | GIPC1 | GIPC PDZ domain containing family, member 1 |
|
NAS | 19 | 14,588,571 | 14,606,961 | RGD:2290271 | UniProtKB | ||
| G | GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
|
IEA | 19 | 3,094,408 | 3,121,468 | RGD:2290271 | InterPro | ||
| G | GNA12 | guanine nucleotide binding protein (G protein) alpha 12 |
|
TAS | 7 | 2,767,739 | 2,883,959 | RGD:2290271 | PINC | ||
| G | GNA12 | guanine nucleotide binding protein (G protein) alpha 12 |
|
IEA | 7 | 2,767,739 | 2,883,959 | RGD:2290271 | InterPro | ||
| G | GNA12 | guanine nucleotide binding protein (G protein) alpha 12 |
|
IEA | 7 | 2,767,739 | 2,883,959 | RGD:2290271 | InterPro | ||
| G | GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
|
IEA | 19 | 3,136,191 | 3,163,766 | RGD:2290271 | InterPro | ||
| G | GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
ISS | 7 | 79,764,140 | 79,848,725 | RGD:2290271 | BHF-UCL | ||
| G | GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
IEA | 7 | 79,764,140 | 79,848,725 | RGD:2290271 | InterPro | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
IEA | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | InterPro | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
TAS | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | PINC | ||
| G | GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
IEA | 16 | 56,225,251 | 56,391,356 | RGD:2290271 | InterPro | ||
| G | GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
|
IEA | 9 | 80,335,189 | 80,646,219 | RGD:2290271 | InterPro | ||
| G | GNAS | GNAS complex locus |
|
IEA | 20 | 57,414,795 | 57,486,250 | RGD:2290271 | InterPro | ||
| G | GNAS | GNAS complex locus |
|
IEA | 20 | 57,414,795 | 57,486,250 | RGD:2290271 | InterPro | ||
| G | GNAT2 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 |
|
NAS | 1 | 110,145,889 | 110,155,705 | RGD:2290271 | UniProtKB | ||
| G | GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
TAS | 22 | 23,412,669 | 23,467,221 | RGD:2290271 | PINC | ||
| G | GNB1L | guanine nucleotide binding protein (G protein), beta polypeptide 1-like |
|
NAS | 22 | 19,775,934 | 19,842,462 | RGD:2290271 | UniProtKB | ||
| G | GNB2 | guanine nucleotide binding protein (G protein), beta polypeptide 2 |
|
TAS | 7 | 100,271,363 | 100,276,792 | RGD:2290271 | PINC | ||
| G | GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 |
|
TAS | 12 | 6,949,375 | 6,956,557 | RGD:2290271 | PINC | ||
| G | GNB5 | guanine nucleotide binding protein (G protein), beta 5 |
|
IEA | 15 | 52,413,123 | 52,483,565 | RGD:2290271 | ENSEMBL | ||
| G | GNG10 | guanine nucleotide binding protein (G protein), gamma 10 |
|
IEA | 9 | 114,423,851 | 114,432,526 | RGD:2290271 | InterPro | ||
| G | GNG11 | guanine nucleotide binding protein (G protein), gamma 11 |
|
IEA | 7 | 93,551,016 | 93,555,826 | RGD:2290271 | InterPro | ||
| G | GNG12 | guanine nucleotide binding protein (G protein), gamma 12 |
|
IEA | 1 | 68,167,149 | 68,299,155 | RGD:2290271 | InterPro | ||
| G | GNG2 | guanine nucleotide binding protein (G protein), gamma 2 |
|
IEA | 14 | 52,327,022 | 52,436,518 | RGD:2290271 | InterPro | ||
| G | GNG3 | guanine nucleotide binding protein (G protein), gamma 3 |
|
IEA | 11 | 62,475,066 | 62,476,678 | RGD:2290271 | InterPro | ||
| G | GNG4 | guanine nucleotide binding protein (G protein), gamma 4 |
|
IEA | 1 | 235,710,985 | 235,814,054 | RGD:2290271 | InterPro | ||
| G | GNG5 | guanine nucleotide binding protein (G protein), gamma 5 |
|
NAS | 1 | 84,964,006 | 84,972,262 | RGD:2290271 | UniProtKB | ||
| G | GNG7 | guanine nucleotide binding protein (G protein), gamma 7 |
|
IEA | 19 | 2,511,218 | 2,702,746 | RGD:2290271 | InterPro | ||
| G | GNG8 | guanine nucleotide binding protein (G protein), gamma 8 |
|
NAS | 19 | 47,137,333 | 47,137,939 | RGD:2290271 | UniProtKB | ||
| G | GNGT1 | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 |
|
IEA | 7 | 93,535,820 | 93,540,485 | RGD:2290271 | InterPro | ||
| G | GNGT2 | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
|
NAS | 17 | 47,283,596 | 47,287,936 | RGD:2290271 | UniProtKB | ||
| G | GNGT2 | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
|
IEA | 17 | 47,283,596 | 47,287,936 | RGD:2290271 | InterPro | ||
| G | GNRHR | gonadotropin-releasing hormone receptor |
|
TAS | 4 | 68,603,093 | 68,621,804 | RGD:2290271 | PINC | ||
| G | GPER | G protein-coupled estrogen receptor 1 |
|
TAS | 7 | 1,126,443 | 1,133,451 | RGD:2290271 | PINC | ||
| G | GPR1 | G protein-coupled receptor 1 |
|
TAS | 2 | 207,040,040 | 207,082,771 | RGD:2290271 | PINC | ||
| G | GPR1 | G protein-coupled receptor 1 |
|
IEA | 2 | 207,040,040 | 207,082,771 | RGD:2290271 | InterPro | ||
| G | GPR110 | G protein-coupled receptor 110 |
|
TAS | 6 | 46,967,813 | 47,010,082 | RGD:2290271 | GDB | ||
| G | GPR111 | G protein-coupled receptor 111 |
|
TAS | 6 | 47,624,326 | 47,665,533 | RGD:2290271 | GDB | ||
| G | GPR112 | G protein-coupled receptor 112 |
|
TAS | X | 135,383,122 | 135,499,047 | RGD:2290271 | GDB | ||
| G | GPR113 | G protein-coupled receptor 113 |
|
TAS | 2 | 26,531,041 | 26,569,685 | RGD:2290271 | GDB | ||
| G | GPR114 | G protein-coupled receptor 114 |
|
TAS | 16 | 57,576,601 | 57,611,101 | RGD:2290271 | GDB | ||
| G | GPR115 | G protein-coupled receptor 115 |
|
TAS | 6 | 47,666,289 | 47,689,757 | RGD:2290271 | GDB | ||
| G | GPR116 | G protein-coupled receptor 116 |
|
TAS | 6 | 46,820,242 | 46,922,675 | RGD:2290271 | GDB | ||
| G | GPR12 | G protein-coupled receptor 12 |
|
TAS | 13 | 27,329,337 | 27,334,922 | RGD:2290271 | PINC | ||
| G | GPR123 | G protein-coupled receptor 123 |
|
TAS | 10 | 134,901,409 | 134,945,179 | RGD:2290271 | GDB | ||
| G | GPR124 | G protein-coupled receptor 124 |
|
TAS | 8 | 37,654,401 | 37,701,504 | RGD:2290271 | GDB | ||
| G | GPR125 | G protein-coupled receptor 125 |
|
TAS | 4 | 22,388,997 | 22,517,677 | RGD:2290271 | GDB | ||
| G | GPR126 | G protein-coupled receptor 126 |
|
TAS | 6 | 142,623,056 | 142,767,403 | RGD:2290271 | GDB | ||
| G | GPR128 | G protein-coupled receptor 128 |
|
TAS | 3 | 100,328,433 | 100,414,323 | RGD:2290271 | GDB | ||
| G | GPR133 | G protein-coupled receptor 133 |
|
TAS | 12 | 131,438,452 | 131,626,010 | RGD:2290271 | GDB | ||
| G | GPR139 | G protein-coupled receptor 139 |
|
IDA | 16 | 20,043,043 | 20,085,100 | RGD:2290271 | MGI | ||
| G | GPR141 | G protein-coupled receptor 141 |
|
NAS | 7 | 37,779,996 | 37,780,913 | RGD:2290271 | UniProtKB | ||
| G | GPR143 | G protein-coupled receptor 143 |
|
IDA | X | 9,693,453 | 9,734,005 | RGD:2290271 | UniProtKB | ||
| G | GPR143 | G protein-coupled receptor 143 |
|
IMP | X | 9,693,453 | 9,734,005 | RGD:2290271 | UniProtKB | ||
| G | GPR144 | G protein-coupled receptor 144 |
|
TAS | 9 | 127,213,423 | 127,239,379 | RGD:2290271 | GDB | ||
| G | GPR15 | G protein-coupled receptor 15 |
|
TAS | 3 | 98,250,878 | 98,251,960 | RGD:2290271 | PINC | ||
| G | GPR161 | G protein-coupled receptor 161 |
|
ISS | 1 | 168,048,780 | 168,106,905 | RGD:2290271 | UniProtKB | ||
| G | GPR17 | G protein-coupled receptor 17 |
|
TAS | 2 | 128,403,439 | 128,410,213 | RGD:2290271 | PINC | ||
| G | GPR171 | G protein-coupled receptor 171 |
|
NAS | 3 | 150,915,619 | 150,920,988 | RGD:2290271 | UniProtKB | ||
| G | GPR176 | G protein-coupled receptor 176 |
|
TAS | 15 | 40,092,931 | 40,213,093 | RGD:2290271 | PINC | ||
| G | GPR18 | G protein-coupled receptor 18 |
|
NAS | 13 | 99,906,967 | 99,910,682 | RGD:2290271 | UniProtKB | ||
| G | GPR180 | G protein-coupled receptor 180 |
|
IEA | 13 | 95,254,104 | 95,286,899 | RGD:2290271 | InterPro | ||
| G | GPR183 | G protein-coupled receptor 183 |
|
IDA | 13 | 99,946,789 | 99,959,749 | RGD:2290271 | UniProtKB | ||
| G | GPR19 | G protein-coupled receptor 19 |
|
TAS | 12 | 12,813,995 | 12,849,121 | RGD:2290271 | PINC | ||
| G | GPR20 | G protein-coupled receptor 20 |
|
IDA | 8 | 142,366,585 | 142,377,365 | RGD:2290271 | UniProtKB | ||
| G | GPR21 | G protein-coupled receptor 21 |
|
TAS | 9 | 125,796,846 | 125,797,895 | RGD:2290271 | PINC | ||
| G | GPR22 | G protein-coupled receptor 22 |
|
TAS | 7 | 107,110,502 | 107,116,125 | RGD:2290271 | PINC | ||
| G | GPR25 | G protein-coupled receptor 25 |
|
TAS | 1 | 200,842,166 | 200,843,251 | RGD:2290271 | PINC | ||
| G | GPR31 | G protein-coupled receptor 31 |
|
TAS | 6 | 167,570,360 | 167,571,319 | RGD:2290271 | PINC | ||
| G | GPR32 | G protein-coupled receptor 32 |
|
TAS | 19 | 51,273,858 | 51,274,928 | RGD:2290271 | PINC | ||
| G | GPR34 | G protein-coupled receptor 34 |
|
TAS | X | 41,548,226 | 41,556,530 | RGD:2290271 | PINC | ||
| G | GPR35 | G protein-coupled receptor 35 |
|
IDA | 2 | 241,544,825 | 241,570,676 | RGD:2290271 | UniProtKB | ||
| G | GPR37 | G protein-coupled receptor 37 (endothelin receptor type B-like) |
|
TAS | 7 | 124,385,655 | 124,406,079 | RGD:2290271 | PINC | ||
| G | GPR39 | G protein-coupled receptor 39 |
|
TAS | 2 | 133,174,147 | 133,404,169 | RGD:2290271 | PINC | ||
| G | GPR4 | G protein-coupled receptor 4 |
|
TAS | 19 | 46,093,022 | 46,105,466 | RGD:2290271 | PINC | ||
| G | GPR42 | G protein-coupled receptor 42 (gene/pseudogene) |
|
TAS | 19 | 35,862,262 | 35,863,302 | RGD:2290271 | PINC | ||
| G | GPR50 | G protein-coupled receptor 50 |
|
TAS | X | 150,345,056 | 150,349,937 | RGD:2290271 | PINC | ||
| G | GPR52 | G protein-coupled receptor 52 |
|
TAS | 1 | 174,417,212 | 174,418,683 | RGD:2290271 | PINC | ||
| G | GPR55 | G protein-coupled receptor 55 |
|
TAS | 2 | 231,772,043 | 231,789,941 | RGD:2290271 | PINC | ||
| G | GPR56 | G protein-coupled receptor 56 |
|
TAS | 16 | 57,653,910 | 57,698,944 | RGD:2290271 | PINC | ||
| G | GPR56 | G protein-coupled receptor 56 |
|
TAS | 16 | 57,653,910 | 57,698,944 | RGD:2290271 | GDB | ||
| G | GPR6 | G protein-coupled receptor 6 |
|
TAS | 6 | 110,300,298 | 110,301,923 | RGD:2290271 | PINC | ||
| G | GPR64 | G protein-coupled receptor 64 |
|
TAS | X | 19,007,425 | 19,140,755 | RGD:2290271 | PINC | ||
| G | GPR65 | G protein-coupled receptor 65 |
|
IDA | 14 | 88,471,468 | 88,481,155 | RGD:2290271 | BHF-UCL | ||
| G | GPR68 | G protein-coupled receptor 68 |
|
TAS | 14 | 91,698,876 | 91,720,224 | RGD:2290271 | PINC | ||
| G | GPR75 | G protein-coupled receptor 75 |
|
TAS | 2 | 54,080,050 | 54,087,170 | RGD:2290271 | PINC | ||
| G | GPR88 | G protein-coupled receptor 88 |
|
NAS | 1 | 101,003,728 | 101,007,583 | RGD:2290271 | UniProtKB | ||
| G | GPR98 | G protein-coupled receptor 98 |
|
TAS | 5 | 89,854,617 | 90,460,033 | RGD:2290271 | GDB | ||
| G | GPRC5C | G protein-coupled receptor, family C, group 5, member C |
|
TAS | 17 | 72,427,667 | 72,443,568 | RGD:2290271 | PINC | ||
| G | GPSM2 | G-protein signaling modulator 2 |
|
TAS | 1 | 109,419,603 | 109,473,044 | RGD:2290271 | PINC | ||
| G | GRM1 | glutamate receptor, metabotropic 1 |
|
TAS | 6 | 146,348,782 | 146,758,731 | RGD:2290271 | PINC | ||
| G | GRM7 | glutamate receptor, metabotropic 7 |
|
IEA | 3 | 6,902,802 | 7,783,218 | RGD:2290271 | InterPro | ||
| G | GRM7 | glutamate receptor, metabotropic 7 |
|
IEA | 3 | 6,902,802 | 7,783,218 | RGD:2290271 | InterPro | ||
| G | GRPR | gastrin-releasing peptide receptor |
|
TAS | X | 16,141,424 | 16,171,641 | RGD:2290271 | PINC | ||
| G | HCAR3 | hydroxycarboxylic acid receptor 3 |
|
TAS | 12 | 123,199,303 | 123,201,439 | RGD:2290271 | PINC | ||
| G | HRH1 | histamine receptor H1 |
|
TAS | 3 | 11,178,779 | 11,304,939 | RGD:2290271 | PINC | ||
| G | HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
TAS | 5 | 63,255,875 | 63,258,119 | RGD:2290271 | PINC | ||
| G | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
TAS | 6 | 78,171,948 | 78,173,120 | RGD:2290271 | PINC | ||
| G | HTR1E | 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
|
TAS | 6 | 87,647,024 | 87,726,397 | RGD:2290271 | PINC | ||
| G | HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
IMP | 2 | 231,972,947 | 231,989,824 | RGD:2290271 | UniProtKB | ||
| G | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
TAS | 5 | 147,830,595 | 148,033,739 | RGD:2290271 | PINC | ||
| G | HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
TAS | 7 | 154,862,034 | 154,879,102 | RGD:2290271 | PINC | ||
| G | IL8 | interleukin 8 |
|
TAS | 4 | 74,606,223 | 74,609,433 | RGD:2290271 | PINC | ||
| G | INPP5K | inositol polyphosphate-5-phosphatase K |
|
ISS | 17 | 1,397,871 | 1,420,182 | RGD:2290271 | UniProtKB | ||
| G | INS | insulin |
|
IDA | 11 | 2,181,009 | 2,182,439 | RGD:2290271 | BHF-UCL | ||
| G | INSR | insulin receptor |
|
IDA | 19 | 7,112,266 | 7,294,011 | RGD:2290271 | BHF-UCL | ||
| G | ITPR3 | inositol 1,4,5-trisphosphate receptor, type 3 |
|
ISS | 6 | 33,589,156 | 33,664,351 | RGD:2290271 | BHF-UCL | ||
| G | JAK2 | Janus kinase 2 |
|
IEA | 9 | 4,985,245 | 5,128,183 | RGD:2290271 | ENSEMBL | ||
| G | KCNK2 | potassium channel, subfamily K, member 2 |
|
IEA | 1 | 215,178,885 | 215,410,436 | RGD:2290271 | ENSEMBL | ||
| G | KISS1R | KISS1 receptor |
|
NAS | 19 | 917,342 | 921,015 | RGD:2290271 | UniProtKB | ||
| G | LANCL1 | LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
NOT | IDA | 2 | 211,295,973 | 211,341,499 | RGD:2290271 | UniProtKB | |
| G | LGR5 | leucine-rich repeat containing G protein-coupled receptor 5 |
|
TAS | 12 | 71,833,813 | 71,978,622 | RGD:2290271 | PINC | ||
| G | LHCGR | luteinizing hormone/choriogonadotropin receptor |
|
TAS | 2 | 48,913,913 | 48,982,880 | RGD:2290271 | PINC | ||
| G | LPAR1 | lysophosphatidic acid receptor 1 |
|
TAS | 9 | 113,636,054 | 113,800,365 | RGD:2290271 | PINC | ||
| G | LPAR2 | lysophosphatidic acid receptor 2 |
|
TAS | 19 | 19,734,464 | 19,739,039 | RGD:2290271 | PINC | ||
| G | LPAR2 | lysophosphatidic acid receptor 2 |
|
IEA | 19 | 19,734,464 | 19,739,039 | RGD:2290271 | ENSEMBL | ||
| G | LPAR4 | lysophosphatidic acid receptor 4 |
|
TAS | X | 78,003,206 | 78,012,588 | RGD:2290271 | PINC | ||
| G | LPAR6 | lysophosphatidic acid receptor 6 |
|
NAS | 13 | 48,985,181 | 49,018,840 | RGD:2290271 | UniProtKB | ||
| G | LPHN1 | latrophilin 1 |
|
TAS | 19 | 14,258,549 | 14,316,997 | RGD:2290271 | GDB | ||
| G | LPHN2 | latrophilin 2 |
|
NAS | 1 | 82,266,082 | 82,458,107 | RGD:2290271 | UniProtKB | ||
| G | LPHN3 | latrophilin 3 |
|
NAS | 4 | 62,362,839 | 62,938,168 | RGD:2290271 | UniProtKB | ||
| G | LTB4R | leukotriene B4 receptor |
|
TAS | 14 | 24,780,705 | 24,787,242 | RGD:2290271 | PINC | ||
| G | MAS1 | MAS1 oncogene |
|
TAS | 6 | 160,327,974 | 160,329,108 | RGD:2290271 | PINC | ||
| G | MAS1L | MAS1 oncogene-like |
|
NAS | 6 | 29,454,543 | 29,455,679 | RGD:2290271 | UniProtKB | ||
| G | MC2R | melanocortin 2 receptor (adrenocorticotropic hormone) |
|
TAS | 18 | 13,882,043 | 13,915,535 | RGD:2290271 | PINC | ||
| G | MCHR1 | melanin-concentrating hormone receptor 1 |
|
TAS | 22 | 41,075,182 | 41,078,818 | RGD:2290271 | PINC | ||
| G | MLN | motilin |
|
TAS | 6 | 33,762,449 | 33,771,793 | RGD:2290271 | PINC | ||
| G | MLNR | motilin receptor |
|
TAS | 13 | 49,794,474 | 49,796,513 | RGD:2290271 | PINC | ||
| G | MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 |
|
TAS | 11 | 59,856,137 | 59,865,940 | RGD:2290271 | PINC | ||
| G | NMBR | neuromedin B receptor |
|
TAS | 6 | 142,396,745 | 142,409,936 | RGD:2290271 | PINC | ||
| G | NMU | neuromedin U |
|
TAS | 4 | 56,461,398 | 56,502,465 | RGD:2290271 | PINC | ||
| G | NMUR1 | neuromedin U receptor 1 |
|
TAS | 2 | 232,387,871 | 232,395,182 | RGD:2290271 | PINC | ||
| G | NPB | neuropeptide B |
|
IDA | 17 | 79,860,072 | 79,860,781 | RGD:2290271 | HGNC | ||
| G | NPBWR1 | neuropeptides B/W receptor 1 |
|
IDA | 8 | 53,852,468 | 53,853,454 | RGD:2290271 | HGNC | ||
| G | NPBWR2 | neuropeptides B/W receptor 2 |
|
IDA | 20 | 62,737,183 | 62,738,184 | RGD:2290271 | HGNC | ||
| G | NPFFR2 | neuropeptide FF receptor 2 |
|
TAS | 4 | 72,897,521 | 73,013,918 | RGD:2290271 | PINC | ||
| G | NPW | neuropeptide W |
|
IDA | 16 | 2,069,521 | 2,070,756 | RGD:2290271 | HGNC | ||
| G | NPW | neuropeptide W |
|
IEA | 16 | 2,069,521 | 2,070,756 | RGD:2290271 | ENSEMBL | ||
| G | NPY4R | neuropeptide Y receptor Y4 |
|
TAS | 10 | 47,083,534 | 47,088,320 | RGD:2290271 | PINC | ||
| G | NPY5R | neuropeptide Y receptor Y5 |
|
TAS | 4 | 164,265,091 | 164,273,086 | RGD:2290271 | PINC | ||
| G | NPY6R | neuropeptide Y receptor Y6 (pseudogene) |
|
NOT | IKR | 5 | 137,136,882 | 137,146,440 | RGD:2290271 | UniProtKB | |
| G | NPY6R | neuropeptide Y receptor Y6 (pseudogene) |
|
NOT | IKR | 5 | 137,136,882 | 137,146,440 | RGD:2290271 | UniProtKB | |
| G | NTSR1 | neurotensin receptor 1 (high affinity) |
|
TAS | 20 | 61,340,189 | 61,394,123 | RGD:2290271 | PINC | ||
| G | OPN1MW | opsin 1 (cone pigments), medium-wave-sensitive |
|
TAS | X | 153,448,085 | 153,462,352 | RGD:2290271 | PINC | ||
| G | OPN1MW2 | opsin 1 (cone pigments), medium-wave-sensitive 2 |
|
TAS | X | 153,485,203 | 153,498,755 | RGD:2290271 | PINC | ||
| G | OPN3 | opsin 3 |
|
TAS | 1 | 241,756,452 | 241,803,701 | RGD:2290271 | PINC | ||
| G | OPRD1 | opioid receptor, delta 1 |
|
IDA | 1 | 29,138,654 | 29,190,208 | RGD:2290271 | UniProtKB | ||
| G | OR10AB1P | olfactory receptor, family 10, subfamily AB, member 1 pseudogene |
|
IEA | 11 | 7,749,948 | 7,750,885 | RGD:2290271 | InterPro | ||
| G | OR10J1 | olfactory receptor, family 10, subfamily J, member 1 |
|
TAS | 1 | 159,409,512 | 159,410,600 | RGD:2290271 | PINC | ||
| G | OR1D2 | olfactory receptor, family 1, subfamily D, member 2 |
|
IDA | 17 | 2,995,352 | 2,996,290 | RGD:2290271 | UniProtKB | ||
| G | OR1D4 | olfactory receptor, family 1, subfamily D, member 4 (gene/pseudogene) |
|
TAS | 17 | 3,143,970 | 3,144,559 | RGD:2290271 | PINC | ||
| G | OR1D5 | olfactory receptor, family 1, subfamily D, member 5 |
|
TAS | 17 | 2,965,963 | 2,966,901 | RGD:2290271 | PINC | ||
| G | OXER1 | oxoeicosanoid (OXE) receptor 1 |
|
NAS | 2 | 42,989,639 | 42,991,401 | RGD:2290271 | UniProtKB | ||
| G | OXGR1 | oxoglutarate (alpha-ketoglutarate) receptor 1 |
|
TAS | 13 | 97,637,973 | 97,646,604 | RGD:2290271 | UniProtKB | ||
| G | P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 |
|
ISS | 3 | 152,552,736 | 152,555,845 | RGD:2290271 | BHF-UCL | ||
| G | P2RY11 | purinergic receptor P2Y, G-protein coupled, 11 |
|
IDA | 19 | 10,222,197 | 10,226,065 | RGD:2290271 | BHF-UCL | ||
| G | P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 |
|
IEA | 3 | 150,929,905 | 150,996,230 | RGD:2290271 | InterPro | ||
| G | P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 |
|
NAS | 3 | 150,929,905 | 150,996,230 | RGD:2290271 | UniProtKB | ||
| G | PDC | phosducin |
|
TAS | 1 | 186,412,698 | 186,430,240 | RGD:2290271 | PINC | ||
| G | PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
|
TAS | 3 | 138,371,540 | 138,478,201 | RGD:2290271 | UniProtKB | ||
| G | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
IDA | 7 | 106,505,924 | 106,547,592 | RGD:2290271 | UniProtKB | ||
| G | PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 |
|
ISS | 17 | 8,782,233 | 8,869,029 | RGD:2290271 | UniProtKB | ||
| G | PIK3R6 | phosphoinositide-3-kinase, regulatory subunit 6 |
|
ISS | 17 | 8,706,055 | 8,770,994 | RGD:2290271 | UniProtKB | ||
| G | PREX2 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
|
IDA | 8 | 68,864,603 | 69,143,897 | RGD:2290271 | MGI | ||
| G | PRLH | prolactin releasing hormone |
|
IEA | 2 | 238,475,217 | 238,475,818 | RGD:2290271 | ENSEMBL | ||
| G | PRLHR | prolactin releasing hormone receptor |
|
TAS | 10 | 120,352,916 | 120,355,160 | RGD:2290271 | PINC | ||
| G | PROK2 | prokineticin 2 |
|
NAS | 3 | 71,820,806 | 71,834,357 | RGD:2290271 | UniProtKB | ||
| G | PTAFR | platelet-activating factor receptor |
|
IMP | 1 | 28,473,677 | 28,520,447 | RGD:2290271 | UniProtKB | ||
| G | PTGDR | prostaglandin D2 receptor (DP) |
|
NAS | 14 | 52,734,431 | 52,743,442 | RGD:2290271 | UniProtKB | ||
| G | PTGDR2 | prostaglandin D2 receptor 2 |
|
IDA | 11 | 60,618,398 | 60,623,444 | RGD:2290271 | UniProtKB | ||
| G | PTGER1 | prostaglandin E receptor 1 (subtype EP1), 42kDa |
|
TAS | 19 | 14,583,278 | 14,586,174 | RGD:2290271 | PINC | ||
| G | PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa |
|
TAS | 14 | 52,781,016 | 52,795,324 | RGD:2290271 | PINC | ||
| G | PTGER3 | prostaglandin E receptor 3 (subtype EP3) |
|
TAS | 1 | 71,318,036 | 71,513,491 | RGD:2290271 | PINC | ||
| G | PTGFR | prostaglandin F receptor (FP) |
|
TAS | 1 | 78,956,728 | 79,006,386 | RGD:2290271 | PINC | ||
| G | PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) |
|
IEA | 19 | 47,123,725 | 47,128,354 | RGD:2290271 | InterPro | ||
| G | PTH | parathyroid hormone |
|
TAS | 11 | 13,513,601 | 13,517,567 | RGD:2290271 | PINC | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
TAS | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | PINC | ||
| G | PTH2R | parathyroid hormone 2 receptor |
|
TAS | 2 | 209,271,556 | 209,359,231 | RGD:2290271 | PINC | ||
| G | PTPN6 | protein tyrosine phosphatase, non-receptor type 6 |
|
TAS | 12 | 7,055,740 | 7,070,479 | RGD:2290271 | PINC | ||
| G | PYY | peptide YY |
|
TAS | 17 | 42,030,106 | 42,081,837 | RGD:2290271 | PINC | ||
| G | QRFPR | pyroglutamylated RFamide peptide receptor |
|
IDA | 4 | 122,249,797 | 122,302,181 | RGD:2290271 | UniProtKB | ||
| G | RAMP1 | receptor (G protein-coupled) activity modifying protein 1 |
|
IEA | 2 | 238,768,187 | 238,820,756 | RGD:2290271 | ENSEMBL | ||
| G | RAMP2 | receptor (G protein-coupled) activity modifying protein 2 |
|
IEA | 17 | 40,913,212 | 40,915,059 | RGD:2290271 | ENSEMBL | ||
| G | RAMP3 | receptor (G protein-coupled) activity modifying protein 3 |
|
IEA | 7 | 45,197,367 | 45,223,849 | RGD:2290271 | ENSEMBL | ||
| G | RAPGEF4 | Rap guanine nucleotide exchange factor (GEF) 4 |
|
TAS | 2 | 173,600,525 | 173,917,621 | RGD:2290271 | PINC | ||
| G | RAPGEFL1 | Rap guanine nucleotide exchange factor (GEF)-like 1 |
|
TAS | 17 | 38,334,242 | 38,351,906 | RGD:2290271 | PINC | ||
| G | RASD1 | RAS, dexamethasone-induced 1 |
|
TAS | 17 | 17,397,751 | 17,399,709 | RGD:2290271 | PINC | ||
| G | RGR | retinal G protein coupled receptor |
|
TAS | 10 | 86,004,809 | 86,018,944 | RGD:2290271 | PINC | ||
| G | RGS11 | regulator of G-protein signaling 11 |
|
IEA | 16 | 318,310 | 325,914 | RGD:2290271 | InterPro | ||
| G | RGS13 | regulator of G-protein signaling 13 |
|
IEA | 1 | 192,605,268 | 192,629,441 | RGD:2290271 | ENSEMBL | ||
| G | RGS18 | regulator of G-protein signaling 18 |
|
IEA | 1 | 192,127,592 | 192,154,945 | RGD:2290271 | ENSEMBL | ||
| G | RGS19 | regulator of G-protein signaling 19 |
|
TAS | 20 | 62,704,534 | 62,711,324 | RGD:2290271 | PINC | ||
| G | RGS6 | regulator of G-protein signaling 6 |
|
IEA | 14 | 72,398,817 | 73,033,238 | RGD:2290271 | InterPro | ||
| G | RGS7 | regulator of G-protein signaling 7 |
|
IEA | 1 | 240,938,817 | 241,520,478 | RGD:2290271 | InterPro | ||
| G | RGS7BP | regulator of G-protein signaling 7 binding protein |
|
IEA | 5 | 63,802,452 | 63,908,126 | RGD:2290271 | ENSEMBL | ||
| G | RGS9 | regulator of G-protein signaling 9 |
|
IEA | 17 | 63,133,456 | 63,223,821 | RGD:2290271 | InterPro | ||
| G | RHO | rhodopsin |
|
TAS | 3 | 129,247,482 | 129,254,187 | RGD:2290271 | PINC | ||
| G | RRH | retinal pigment epithelium-derived rhodopsin homolog |
|
TAS | 4 | 110,749,150 | 110,765,863 | RGD:2290271 | PINC | ||
| G | RXFP3 | relaxin/insulin-like family peptide receptor 3 |
|
TAS | 5 | 33,936,491 | 33,939,023 | RGD:2290271 | PINC | ||
| G | S1PR1 | sphingosine-1-phosphate receptor 1 |
|
TAS | 1 | 101,702,305 | 101,707,076 | RGD:2290271 | PINC | ||
| G | S1PR2 | sphingosine-1-phosphate receptor 2 |
|
TAS | 19 | 10,332,109 | 10,341,948 | RGD:2290271 | PINC | ||
| G | S1PR3 | sphingosine-1-phosphate receptor 3 |
|
TAS | 9 | 91,606,324 | 91,620,070 | RGD:2290271 | PINC | ||
| G | S1PR4 | sphingosine-1-phosphate receptor 4 |
|
TAS | 19 | 3,178,736 | 3,180,330 | RGD:2290271 | PINC | ||
| G | SCTR | secretin receptor |
|
TAS | 2 | 120,197,419 | 120,282,028 | RGD:2290271 | PINC | ||
| G | SORT1 | sortilin 1 |
|
IMP | 1 | 109,852,187 | 109,940,563 | RGD:2290271 | BHF-UCL | ||
| G | SST | somatostatin |
|
TAS | 3 | 187,386,694 | 187,388,201 | RGD:2290271 | UniProtKB | ||
| G | SSTR4 | somatostatin receptor 4 |
|
TAS | 20 | 23,016,057 | 23,017,314 | RGD:2290271 | PINC | ||
| G | SSTR5 | somatostatin receptor 5 |
|
TAS | 16 | 1,122,756 | 1,131,454 | RGD:2290271 | PINC | ||
| G | TAAR1 | trace amine associated receptor 1 |
|
TAS | 6 | 132,966,123 | 132,967,142 | RGD:2290271 | GDB | ||
| G | TAAR2 | trace amine associated receptor 2 |
|
TAS | 6 | 132,938,289 | 132,945,414 | RGD:2290271 | GDB | ||
| G | TAAR5 | trace amine associated receptor 5 |
|
TAS | 6 | 132,909,731 | 132,910,877 | RGD:2290271 | GDB | ||
| G | TAAR6 | trace amine associated receptor 6 |
|
TAS | 6 | 132,891,461 | 132,892,498 | RGD:2290271 | GDB | ||
| G | TAAR8 | trace amine associated receptor 8 |
|
TAS | 6 | 132,873,832 | 132,874,860 | RGD:2290271 | GDB | ||
| G | TAAR9 | trace amine associated receptor 9 (gene/pseudogene) |
|
TAS | 6 | 132,859,427 | 132,860,475 | RGD:2290271 | GDB | ||
| G | TAS1R2 | taste receptor, type 1, member 2 |
|
IC | 1 | 19,166,093 | 19,186,155 | RGD:2290271 | HGNC | ||
| G | TAS1R3 | taste receptor, type 1, member 3 |
|
IC | 1 | 1,266,726 | 1,269,844 | RGD:2290271 | HGNC | ||
| G | TAS2R1 | taste receptor, type 2, member 1 |
|
TAS | 5 | 9,629,109 | 9,630,463 | RGD:2290271 | PINC | ||
| G | TAS2R14 | taste receptor, type 2, member 14 |
|
IC | 12 | 11,090,853 | 11,091,806 | RGD:2290271 | HGNC | ||
| G | TAS2R16 | taste receptor, type 2, member 16 |
|
IC | 7 | 122,634,759 | 122,635,754 | RGD:2290271 | HGNC | ||
| G | TAS2R43 | taste receptor, type 2, member 43 |
|
IC | 12 | 11,243,886 | 11,244,912 | RGD:2290271 | HGNC | ||
| G | TBXA2R | thromboxane A2 receptor |
|
TAS | 19 | 3,594,504 | 3,606,831 | RGD:2290271 | PINC | ||
| G | TMEM145 | transmembrane protein 145 |
|
IEA | 19 | 42,817,477 | 42,829,214 | RGD:2290271 | InterPro | ||
| G | TPRA1 | transmembrane protein, adipocyte asscociated 1 |
|
TAS | 3 | 127,291,908 | 127,309,568 | RGD:2290271 | GOC | ||
| G | TRHR | thyrotropin-releasing hormone receptor |
|
TAS | 8 | 110,099,653 | 110,131,813 | RGD:2290271 | PINC | ||
| G | TSHB | thyroid stimulating hormone, beta |
|
TAS | 1 | 115,572,415 | 115,576,941 | RGD:2290271 | PINC | ||
| G | TSHR | thyroid stimulating hormone receptor |
|
TAS | 14 | 81,421,869 | 81,612,646 | RGD:2290271 | PINC | ||
| G | TULP3 | tubby like protein 3 |
|
NAS | 12 | 3,000,033 | 3,050,306 | RGD:2290271 | UniProtKB | ||
| G | UCN | urocortin |
|
TAS | 2 | 27,530,265 | 27,531,130 | RGD:2290271 | PINC | ||
| G | VIP | vasoactive intestinal peptide |
|
TAS | 6 | 153,071,932 | 153,080,900 | RGD:2290271 | PINC | ||
| G | VIPR1 | vasoactive intestinal peptide receptor 1 |
|
TAS | 3 | 42,530,791 | 42,579,065 | RGD:2290271 | PINC | ||
| G | XCR1 | chemokine (C motif) receptor 1 |
|
TAS | 3 | 46,062,291 | 46,068,979 | RGD:2290271 | PINC | ||
| G | XPR1 | xenotropic and polytropic retrovirus receptor 1 |
|
TAS | 1 | 180,601,146 | 180,859,415 | RGD:2290271 | PINC | ||
adaptation of rhodopsin mediated signaling
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) |
|
IEA | 14 | 68,143,517 | 68,162,510 | RGD:2290271 | ENSEMBL | ||
| G | RS1 | retinoschisin 1 |
|
IEA | X | 18,657,808 | 18,690,223 | RGD:2290271 | ENSEMBL | ||
adenosine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCY5 | adenylate cyclase 5 |
|
IEA | 3 | 123,001,143 | 123,167,392 | RGD:2290271 | ENSEMBL | ||
| G | DLG4 | discs, large homolog 4 (Drosophila) |
|
ISS | 17 | 7,093,209 | 7,123,369 | RGD:2290271 | BHF-UCL | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
IBA | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | RefGenome | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
IEA | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | ENSEMBL | ||
adenylate cyclase-activating dopamine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCY5 | adenylate cyclase 5 |
|
IEA | 3 | 123,001,143 | 123,167,392 | RGD:2290271 | ENSEMBL | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | BHF-UCL | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | BHF-UCL | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | BHF-UCL | ||
| G | DRD3 | dopamine receptor D3 |
|
IDA | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | BHF-UCL | ||
| G | DRD5 | dopamine receptor D5 |
|
IDA | 4 | 9,783,258 | 9,785,633 | RGD:2290271 | UniProtKB | ||
| G | DRD5 | dopamine receptor D5 |
|
IDA | 4 | 9,783,258 | 9,785,633 | RGD:2290271 | BHF-UCL | ||
| G | GNAL | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
|
IEA | 18 | 11,689,014 | 11,885,684 | RGD:2290271 | ENSEMBL | ||
| G | GNAL | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
|
IBA | 18 | 11,689,014 | 11,885,684 | RGD:2290271 | RefGenome | ||
| G | GNAS | GNAS complex locus |
|
ISS | 20 | 57,414,795 | 57,486,250 | RGD:2290271 | BHF-UCL | ||
| G | GNAS | GNAS complex locus |
|
IBA | 20 | 57,414,795 | 57,486,250 | RGD:2290271 | RefGenome | ||
| G | GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
ISS | 1 | 1,716,725 | 1,822,526 | RGD:2290271 | BHF-UCL | ||
| G | GNG2 | guanine nucleotide binding protein (G protein), gamma 2 |
|
ISS | 14 | 52,327,022 | 52,436,518 | RGD:2290271 | BHF-UCL | ||
| G | OPRM1 | opioid receptor, mu 1 |
|
IEA | 6 | 154,331,631 | 154,568,001 | RGD:2290271 | ENSEMBL | ||
| G | SLC9A3R1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
IEA | 17 | 72,744,751 | 72,765,499 | RGD:2290271 | ENSEMBL | ||
adenylate cyclase-activating G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCY1 | adenylate cyclase 1 (brain) |
|
TAS | 7 | 45,614,125 | 45,762,715 | RGD:2290271 | Reactome | ||
| G | ADCY2 | adenylate cyclase 2 (brain) |
|
TAS | 5 | 7,396,343 | 7,830,194 | RGD:2290271 | Reactome | ||
| G | ADCY3 | adenylate cyclase 3 |
|
TAS | 2 | 25,042,038 | 25,142,055 | RGD:2290271 | Reactome | ||
| G | ADCY4 | adenylate cyclase 4 |
|
TAS | 14 | 24,787,555 | 24,804,277 | RGD:2290271 | Reactome | ||
| G | ADCY5 | adenylate cyclase 5 |
|
TAS | 3 | 123,001,143 | 123,167,392 | RGD:2290271 | Reactome | ||
| G | ADCY6 | adenylate cyclase 6 |
|
TAS | 12 | 49,159,975 | 49,182,820 | RGD:2290271 | Reactome | ||
| G | ADCY7 | adenylate cyclase 7 |
|
TAS | 16 | 50,321,823 | 50,352,043 | RGD:2290271 | Reactome | ||
| G | ADCY8 | adenylate cyclase 8 (brain) |
|
TAS | 8 | 131,792,547 | 132,052,835 | RGD:2290271 | Reactome | ||
| G | ADCY9 | adenylate cyclase 9 |
|
TAS | 16 | 4,012,650 | 4,166,186 | RGD:2290271 | Reactome | ||
| G | ADM2 | adrenomedullin 2 |
|
IEA | 22 | 50,919,985 | 50,924,866 | RGD:2290271 | ENSEMBL | ||
| G | ADORA2A | adenosine A2a receptor |
|
IEA | 22 | 24,823,530 | 24,838,325 | RGD:2290271 | ENSEMBL | ||
| G | ADORA2A | adenosine A2a receptor |
|
IEA | 22 | 24,823,530 | 24,838,325 | RGD:2290271 | ENSEMBL | ||
| G | ADORA2B | adenosine A2b receptor |
|
IEA | 17 | 15,848,231 | 15,879,210 | RGD:2290271 | ENSEMBL | ||
| G | ADRB1 | adrenoceptor beta 1 |
|
IEA | 10 | 115,803,806 | 115,806,667 | RGD:2290271 | ENSEMBL | ||
| G | ADRB2 | adrenoceptor beta 2, surface |
|
IEA | 5 | 148,206,156 | 148,208,197 | RGD:2290271 | ENSEMBL | ||
| G | ADRB3 | adrenoceptor beta 3 |
|
IEA | 8 | 37,820,513 | 37,824,184 | RGD:2290271 | ENSEMBL | ||
| G | ADRB3 | adrenoceptor beta 3 |
|
IEA | 8 | 37,820,513 | 37,824,184 | RGD:2290271 | ENSEMBL | ||
| G | CALCA | calcitonin-related polypeptide alpha |
|
IEA | 11 | 14,988,215 | 14,993,832 | RGD:2290271 | ENSEMBL | ||
| G | CALCR | calcitonin receptor |
|
NAS | 7 | 93,053,799 | 93,204,042 | RGD:2290271 | UniProtKB | ||
| G | CALCR | calcitonin receptor |
|
IDA | 7 | 93,053,799 | 93,204,042 | RGD:2290271 | UniProtKB | ||
| G | CALCR | calcitonin receptor |
|
IEA | 7 | 93,053,799 | 93,204,042 | RGD:2290271 | ENSEMBL | ||
| G | CALCRL | calcitonin receptor-like |
|
IEA | 2 | 188,207,846 | 188,313,021 | RGD:2290271 | ENSEMBL | ||
| G | CRHR1 | corticotropin releasing hormone receptor 1 |
|
IEA | 17 | 43,697,710 | 43,913,194 | RGD:2290271 | ENSEMBL | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | UniProtKB | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | BHF-UCL | ||
| G | DRD5 | dopamine receptor D5 |
|
IDA | 4 | 9,783,258 | 9,785,633 | RGD:2290271 | UniProtKB | ||
| G | FSHR | follicle stimulating hormone receptor |
|
IEA | 2 | 49,189,296 | 49,381,666 | RGD:2290271 | ENSEMBL | ||
| G | GALR1 | galanin receptor 1 |
|
IEA | 18 | 74,962,008 | 74,982,098 | RGD:2290271 | ENSEMBL | ||
| G | GCGR | glucagon receptor |
|
IEA | 17 | 79,762,010 | 79,771,889 | RGD:2290271 | ENSEMBL | ||
| G | GHRH | growth hormone releasing hormone |
|
ISS | 20 | 35,879,489 | 35,885,299 | RGD:2290271 | BHF-UCL | ||
| G | GHRH | growth hormone releasing hormone |
|
IC | 20 | 35,879,489 | 35,885,299 | RGD:2290271 | BHF-UCL | ||
| G | GHRH | growth hormone releasing hormone |
|
IDA | 20 | 35,879,489 | 35,885,299 | RGD:2290271 | MGI | ||
| G | GHRHR | growth hormone releasing hormone receptor |
|
IDA | 7 | 31,003,636 | 31,019,146 | RGD:2290271 | BHF-UCL | ||
| G | GNA13 | guanine nucleotide binding protein (G protein), alpha 13 |
|
IEA | 17 | 63,005,407 | 63,052,920 | RGD:2290271 | ENSEMBL | ||
| G | GNA13 | guanine nucleotide binding protein (G protein), alpha 13 |
|
IBA | 17 | 63,005,407 | 63,052,920 | RGD:2290271 | RefGenome | ||
| G | GNAL | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
|
TAS | 18 | 11,689,014 | 11,885,684 | RGD:2290271 | Reactome | ||
| G | GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
|
IEA | 9 | 80,335,189 | 80,646,219 | RGD:2290271 | ENSEMBL | ||
| G | GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
|
IBA | 9 | 80,335,189 | 80,646,219 | RGD:2290271 | RefGenome | ||
| G | GPR26 | G protein-coupled receptor 26 |
|
IDA | 10 | 125,425,871 | 125,456,915 | RGD:2290271 | UniProtKB | ||
| G | GPR3 | G protein-coupled receptor 3 |
|
TAS | 1 | 27,719,148 | 27,722,318 | RGD:2290271 | PINC | ||
| G | GPR78 | G protein-coupled receptor 78 |
|
IDA | 4 | 8,581,964 | 8,591,750 | RGD:2290271 | UniProtKB | ||
| G | PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa |
|
ISS | 14 | 52,781,016 | 52,795,324 | RGD:2290271 | BHF-UCL | ||
| G | PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa |
|
IEA | 14 | 52,781,016 | 52,795,324 | RGD:2290271 | ENSEMBL | ||
| G | PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) |
|
IMP | 19 | 47,123,725 | 47,128,354 | RGD:2290271 | BHF-UCL | ||
| G | PTH | parathyroid hormone |
|
IEA | 11 | 13,513,601 | 13,517,567 | RGD:2290271 | ENSEMBL | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
ISS | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | BHF-UCL | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
IEA | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | ENSEMBL | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
IEA | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | ENSEMBL | ||
| G | PTHLH | parathyroid hormone-like hormone |
|
IDA | 12 | 28,111,017 | 28,124,916 | RGD:2290271 | MGI | ||
| G | RXFP2 | relaxin/insulin-like family peptide receptor 2 |
|
IEA | 13 | 32,313,679 | 32,377,009 | RGD:2290271 | ENSEMBL | ||
| G | S1PR4 | sphingosine-1-phosphate receptor 4 |
|
IEA | 19 | 3,178,736 | 3,180,330 | RGD:2290271 | ENSEMBL | ||
| G | TSHR | thyroid stimulating hormone receptor |
|
IEA | 14 | 81,421,869 | 81,612,646 | RGD:2290271 | ENSEMBL | ||
| G | UCN3 | urocortin 3 |
|
IEA | 10 | 5,406,976 | 5,416,169 | RGD:2290271 | ENSEMBL | ||
adenylate cyclase-inhibiting adrenergic receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRA2A | adrenoceptor alpha 2A |
|
IDA | 10 | 112,836,790 | 112,840,665 | RGD:2290271 | BHF-UCL | ||
adenylate cyclase-inhibiting dopamine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCY5 | adenylate cyclase 5 |
|
IEA | 3 | 123,001,143 | 123,167,392 | RGD:2290271 | ENSEMBL | ||
| G | DRD2 | dopamine receptor D2 |
|
IEA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | ENSEMBL | ||
| G | DRD2 | dopamine receptor D2 |
|
IDA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | BHF-UCL | ||
| G | DRD2 | dopamine receptor D2 |
|
IDA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | BHF-UCL | ||
| G | DRD2 | dopamine receptor D2 |
|
IEA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | ENSEMBL | ||
| G | DRD2 | dopamine receptor D2 |
|
IEA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | InterPro | ||
| G | DRD3 | dopamine receptor D3 |
|
IDA | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | BHF-UCL | ||
| G | DRD3 | dopamine receptor D3 |
|
IDA | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | BHF-UCL | ||
| G | DRD3 | dopamine receptor D3 |
|
IEA | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | InterPro | ||
| G | DRD4 | dopamine receptor D4 |
|
IDA | 11 | 637,305 | 640,706 | RGD:2290271 | BHF-UCL | ||
| G | FLNA | filamin A, alpha |
|
IMP | X | 153,576,900 | 153,603,006 | RGD:2290271 | BHF-UCL | ||
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CHRM4 | cholinergic receptor, muscarinic 4 |
|
IEA | 11 | 46,406,640 | 46,408,107 | RGD:2290271 | ENSEMBL | ||
| G | CHRM5 | cholinergic receptor, muscarinic 5 |
|
TAS | 15 | 34,261,089 | 34,357,287 | RGD:2290271 | PINC | ||
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GRIK3 | glutamate receptor, ionotropic, kainate 3 |
|
IDA | 1 | 37,261,128 | 37,499,844 | RGD:2290271 | GOC | ||
| G | GRM4 | glutamate receptor, metabotropic 4 |
|
IMP | 6 | 33,989,623 | 34,123,399 | RGD:2290271 | UniProtKB | ||
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCY1 | adenylate cyclase 1 (brain) |
|
TAS | 7 | 45,614,125 | 45,762,715 | RGD:2290271 | Reactome | ||
| G | ADCY2 | adenylate cyclase 2 (brain) |
|
TAS | 5 | 7,396,343 | 7,830,194 | RGD:2290271 | Reactome | ||
| G | ADCY3 | adenylate cyclase 3 |
|
TAS | 2 | 25,042,038 | 25,142,055 | RGD:2290271 | Reactome | ||
| G | ADCY4 | adenylate cyclase 4 |
|
TAS | 14 | 24,787,555 | 24,804,277 | RGD:2290271 | Reactome | ||
| G | ADCY5 | adenylate cyclase 5 |
|
TAS | 3 | 123,001,143 | 123,167,392 | RGD:2290271 | Reactome | ||
| G | ADCY6 | adenylate cyclase 6 |
|
TAS | 12 | 49,159,975 | 49,182,820 | RGD:2290271 | Reactome | ||
| G | ADCY7 | adenylate cyclase 7 |
|
TAS | 16 | 50,321,823 | 50,352,043 | RGD:2290271 | Reactome | ||
| G | ADCY8 | adenylate cyclase 8 (brain) |
|
TAS | 8 | 131,792,547 | 132,052,835 | RGD:2290271 | Reactome | ||
| G | ADCY9 | adenylate cyclase 9 |
|
TAS | 16 | 4,012,650 | 4,166,186 | RGD:2290271 | Reactome | ||
| G | ADORA1 | adenosine A1 receptor |
|
IEA | 1 | 203,096,836 | 203,136,533 | RGD:2290271 | ENSEMBL | ||
| G | APLP1 | amyloid beta (A4) precursor-like protein 1 |
|
IC | 19 | 36,359,401 | 36,370,699 | RGD:2290271 | BHF-UCL | ||
| G | CORT | cortistatin |
|
IDA | 1 | 10,509,776 | 10,512,060 | RGD:2290271 | UniProtKB | ||
| G | GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
TAS | 7 | 79,764,140 | 79,848,725 | RGD:2290271 | Reactome | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
TAS | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | Reactome | ||
| G | GNAI3 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
|
TAS | 1 | 110,091,186 | 110,138,465 | RGD:2290271 | Reactome | ||
| G | GNAL | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
|
TAS | 18 | 11,689,014 | 11,885,684 | RGD:2290271 | Reactome | ||
| G | GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
IEA | 22 | 23,412,669 | 23,467,221 | RGD:2290271 | ENSEMBL | ||
| G | MCHR1 | melanin-concentrating hormone receptor 1 |
|
TAS | 22 | 41,075,182 | 41,078,818 | RGD:2290271 | PINC | ||
| G | NPR3 | natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
IEA | 5 | 32,710,743 | 32,791,830 | RGD:2290271 | ENSEMBL | ||
| G | NPY1R | neuropeptide Y receptor Y1 |
|
TAS | 4 | 164,245,117 | 164,253,947 | RGD:2290271 | PINC | ||
| G | NPY2R | neuropeptide Y receptor Y2 |
|
TAS | 4 | 156,129,781 | 156,138,228 | RGD:2290271 | PINC | ||
| G | OPRD1 | opioid receptor, delta 1 |
|
IEA | 1 | 29,138,654 | 29,190,208 | RGD:2290271 | ENSEMBL | ||
| G | OPRK1 | opioid receptor, kappa 1 |
|
TAS | 8 | 54,138,276 | 54,164,194 | RGD:2290271 | PINC | ||
| G | OPRL1 | opiate receptor-like 1 |
|
TAS | 20 | 62,711,471 | 62,731,996 | RGD:2290271 | PINC | ||
| G | OPRM1 | opioid receptor, mu 1 |
|
IEA | 6 | 154,331,631 | 154,568,001 | RGD:2290271 | ENSEMBL | ||
| G | P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 |
|
IEA | 3 | 152,552,736 | 152,555,845 | RGD:2290271 | ENSEMBL | ||
| G | PTGDR2 | prostaglandin D2 receptor 2 |
|
IEA | 11 | 60,618,398 | 60,623,444 | RGD:2290271 | ENSEMBL | ||
| G | RGS1 | regulator of G-protein signaling 1 |
|
TAS | 1 | 192,544,857 | 192,549,159 | RGD:2290271 | PINC | ||
| G | RIC8A | resistance to inhibitors of cholinesterase 8 homolog A (C. elegans) |
|
IEA | 11 | 208,530 | 215,113 | RGD:2290271 | ENSEMBL | ||
| G | RXFP2 | relaxin/insulin-like family peptide receptor 2 |
|
IEA | 13 | 32,313,679 | 32,377,009 | RGD:2290271 | ENSEMBL | ||
| G | S1PR1 | sphingosine-1-phosphate receptor 1 |
|
IEA | 1 | 101,702,305 | 101,707,076 | RGD:2290271 | ENSEMBL | ||
| G | S1PR1 | sphingosine-1-phosphate receptor 1 |
|
IEA | 1 | 101,702,305 | 101,707,076 | RGD:2290271 | ENSEMBL | ||
| G | S1PR3 | sphingosine-1-phosphate receptor 3 |
|
IEA | 9 | 91,606,324 | 91,620,070 | RGD:2290271 | ENSEMBL | ||
| G | SSTR2 | somatostatin receptor 2 |
|
IEA | 17 | 71,161,160 | 71,168,094 | RGD:2290271 | ENSEMBL | ||
adenylate cyclase-modulating G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCY2 | adenylate cyclase 2 (brain) |
|
ISS | 5 | 7,396,343 | 7,830,194 | RGD:2290271 | BHF-UCL | ||
| G | ADCY2 | adenylate cyclase 2 (brain) |
|
IEA | 5 | 7,396,343 | 7,830,194 | RGD:2290271 | ENSEMBL | ||
| G | ADCY4 | adenylate cyclase 4 |
|
ISS | 14 | 24,787,555 | 24,804,277 | RGD:2290271 | UniProtKB | ||
| G | ADCY4 | adenylate cyclase 4 |
|
IEA | 14 | 24,787,555 | 24,804,277 | RGD:2290271 | ENSEMBL | ||
| G | ADORA2A | adenosine A2a receptor |
|
TAS | 22 | 24,823,530 | 24,838,325 | RGD:2290271 | PINC | ||
| G | ADRA1B | adrenoceptor alpha 1B |
|
TAS | 5 | 159,343,740 | 159,400,017 | RGD:2290271 | PINC | ||
| G | ADRA1D | adrenoceptor alpha 1D |
|
TAS | 20 | 4,201,278 | 4,229,659 | RGD:2290271 | PINC | ||
| G | ADRB2 | adrenoceptor beta 2, surface |
|
TAS | 5 | 148,206,156 | 148,208,197 | RGD:2290271 | PINC | ||
| G | ADRB3 | adrenoceptor beta 3 |
|
TAS | 8 | 37,820,513 | 37,824,184 | RGD:2290271 | PINC | ||
| G | AVPR2 | arginine vasopressin receptor 2 |
|
TAS | X | 153,167,985 | 153,172,620 | RGD:2290271 | PINC | ||
| G | CACNA1D | calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
ISS | 3 | 53,529,031 | 53,846,492 | RGD:2290271 | BHF-UCL | ||
| G | CCR3 | chemokine (C-C motif) receptor 3 |
|
TAS | 3 | 46,283,872 | 46,308,197 | RGD:2290271 | PINC | ||
| G | CHRM2 | cholinergic receptor, muscarinic 2 |
|
TAS | 7 | 136,553,399 | 136,701,771 | RGD:2290271 | PINC | ||
| G | CNR1 | cannabinoid receptor 1 (brain) |
|
IDA | 6 | 88,849,583 | 88,875,767 | RGD:2290271 | UniProtKB | ||
| G | CRHR1 | corticotropin releasing hormone receptor 1 |
|
TAS | 17 | 43,697,710 | 43,913,194 | RGD:2290271 | PINC | ||
| G | CRHR2 | corticotropin releasing hormone receptor 2 |
|
TAS | 7 | 30,691,559 | 30,739,719 | RGD:2290271 | PINC | ||
| G | FPR1 | formyl peptide receptor 1 |
|
TAS | 19 | 52,249,023 | 52,255,150 | RGD:2290271 | PINC | ||
| G | GALR2 | galanin receptor 2 |
|
TAS | 17 | 74,070,892 | 74,073,573 | RGD:2290271 | PINC | ||
| G | GCGR | glucagon receptor |
|
TAS | 17 | 79,762,010 | 79,771,889 | RGD:2290271 | PINC | ||
| G | GLP2R | glucagon-like peptide 2 receptor |
|
IEA | 17 | 9,729,381 | 9,793,022 | RGD:2290271 | ENSEMBL | ||
| G | GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
|
IBA | 19 | 3,094,408 | 3,121,468 | RGD:2290271 | RefGenome | ||
| G | GNA12 | guanine nucleotide binding protein (G protein) alpha 12 |
|
IBA | 7 | 2,767,739 | 2,883,959 | RGD:2290271 | RefGenome | ||
| G | GNA14 | guanine nucleotide binding protein (G protein), alpha 14 |
|
IBA | 9 | 80,037,995 | 80,263,232 | RGD:2290271 | RefGenome | ||
| G | GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
|
IBA | 19 | 3,136,191 | 3,163,766 | RGD:2290271 | RefGenome | ||
| G | GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
IEA | 7 | 79,764,140 | 79,848,725 | RGD:2290271 | InterPro | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
IEA | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | InterPro | ||
| G | GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
IBA | 16 | 56,225,251 | 56,391,356 | RGD:2290271 | RefGenome | ||
| G | GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
IEA | 16 | 56,225,251 | 56,391,356 | RGD:2290271 | InterPro | ||
| G | GNAT1 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
|
IBA | 3 | 50,229,043 | 50,235,129 | RGD:2290271 | RefGenome | ||
| G | GNAT2 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 |
|
IBA | 1 | 110,145,889 | 110,155,705 | RGD:2290271 | RefGenome | ||
| G | GNAT3 | guanine nucleotide binding protein, alpha transducing 3 |
|
IBA | 7 | 80,087,987 | 80,141,242 | RGD:2290271 | RefGenome | ||
| G | GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
IBA | 22 | 23,412,669 | 23,467,221 | RGD:2290271 | RefGenome | ||
| G | GRK5 | G protein-coupled receptor kinase 5 |
|
TAS | 10 | 120,967,197 | 121,215,131 | RGD:2290271 | PINC | ||
| G | MC3R | melanocortin 3 receptor |
|
IEA | 20 | 54,823,788 | 54,824,871 | RGD:2290271 | ENSEMBL | ||
| G | MC4R | melanocortin 4 receptor |
|
TAS | 18 | 58,038,564 | 58,040,001 | RGD:2290271 | PINC | ||
| G | P2RY12 | purinergic receptor P2Y, G-protein coupled, 12 |
|
IEA | 3 | 151,055,376 | 151,102,544 | RGD:2290271 | ENSEMBL | ||
| G | PRKACB | protein kinase, cAMP-dependent, catalytic, beta |
|
TAS | 1 | 84,543,745 | 84,704,181 | RGD:2290271 | UniProtKB | ||
| G | PTGER3 | prostaglandin E receptor 3 (subtype EP3) |
|
IEA | 1 | 71,318,036 | 71,513,491 | RGD:2290271 | ENSEMBL | ||
| G | PTGER4 | prostaglandin E receptor 4 (subtype EP4) |
|
IDA | 5 | 40,680,032 | 40,693,837 | RGD:2290271 | UniProtKB | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
IDA | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | UniProtKB | ||
| G | RXFP1 | relaxin/insulin-like family peptide receptor 1 |
|
IEA | 4 | 159,442,866 | 159,574,524 | RGD:2290271 | ENSEMBL | ||
| G | WASF2 | WAS protein family, member 2 |
|
TAS | 1 | 27,730,734 | 27,816,678 | RGD:2290271 | PINC | ||
desensitization of G-protein coupled receptor protein signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRBK1 | adrenergic, beta, receptor kinase 1 |
|
ISS | 11 | 67,033,905 | 67,054,029 | RGD:2290271 | BHF-UCL | ||
| G | GRM5 | glutamate receptor, metabotropic 5 |
|
IEA | 11 | 88,237,744 | 88,796,816 | RGD:2290271 | ENSEMBL | ||
desensitization of G-protein coupled receptor protein signaling pathway by arrestin
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRB2 | adrenoceptor beta 2, surface |
|
IDA | 5 | 148,206,156 | 148,208,197 | RGD:2290271 | HGNC | ||
| G | ADRB3 | adrenoceptor beta 3 |
|
NOT | IDA | 8 | 37,820,513 | 37,824,184 | RGD:2290271 | HGNC | |
| G | ARRB2 | arrestin, beta 2 |
|
IMP | 17 | 4,613,789 | 4,624,795 | RGD:2290271 | UniProtKB | ||
dopamine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCY6 | adenylate cyclase 6 |
|
IDA | 12 | 49,159,975 | 49,182,820 | RGD:2290271 | BHF-UCL | ||
| G | CALY | calcyon neuron-specific vesicular protein |
|
IEA | 10 | 135,138,928 | 135,150,475 | RGD:2290271 | InterPro | ||
| G | DRD4 | dopamine receptor D4 |
|
IDA | 11 | 637,305 | 640,706 | RGD:2290271 | BHF-UCL | ||
| G | GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
IBA | 16 | 56,225,251 | 56,391,356 | RGD:2290271 | RefGenome | ||
| G | GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
IEA | 16 | 56,225,251 | 56,391,356 | RGD:2290271 | ENSEMBL | ||
| G | HMP19 | HMP19 protein |
|
IEA | 5 | 173,472,607 | 173,536,182 | RGD:2290271 | InterPro | ||
| G | HTT | huntingtin |
|
IEA | 4 | 3,076,408 | 3,245,687 | RGD:2290271 | ENSEMBL | ||
| G | KLF16 | Kruppel-like factor 16 |
|
IEA | 19 | 1,852,398 | 1,863,564 | RGD:2290271 | ENSEMBL | ||
| G | NSG1 | neuron specific gene family member 1 |
|
IEA | 4 | 4,387,983 | 4,420,785 | RGD:2290271 | InterPro | ||
| G | RGS9 | regulator of G-protein signaling 9 |
|
IEA | 17 | 63,133,456 | 63,223,821 | RGD:2290271 | ENSEMBL | ||
elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AGTR1 | angiotensin II receptor, type 1 |
|
IDA | 3 | 148,415,658 | 148,460,790 | RGD:2290271 | BHF-UCL | ||
| G | CALCA | calcitonin-related polypeptide alpha |
|
IDA | 11 | 14,988,215 | 14,993,832 | RGD:2290271 | UniProtKB | ||
| G | CALCA | calcitonin-related polypeptide alpha |
|
IDA | 11 | 14,988,215 | 14,993,832 | RGD:2290271 | UniProtKB | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | BHF-UCL | ||
| G | DRD2 | dopamine receptor D2 |
|
IDA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | BHF-UCL | ||
| G | EDN1 | endothelin 1 |
|
IEA | 6 | 12,290,529 | 12,297,427 | RGD:2290271 | ENSEMBL | ||
| G | EDNRA | endothelin receptor type A |
|
IEA | 4 | 148,402,069 | 148,466,106 | RGD:2290271 | ENSEMBL | ||
| G | F2R | coagulation factor II (thrombin) receptor |
|
ISS | 5 | 76,011,868 | 76,031,595 | RGD:2290271 | UniProtKB | ||
| G | KISS1 | KiSS-1 metastasis-suppressor |
|
IEA | 1 | 204,159,469 | 204,165,619 | RGD:2290271 | ENSEMBL | ||
| G | LPAR1 | lysophosphatidic acid receptor 1 |
|
IEA | 9 | 113,636,054 | 113,800,365 | RGD:2290271 | ENSEMBL | ||
| G | LPAR3 | lysophosphatidic acid receptor 3 |
|
IEA | 1 | 85,279,086 | 85,358,896 | RGD:2290271 | ENSEMBL | ||
| G | RXFP3 | relaxin/insulin-like family peptide receptor 3 |
|
IEA | 5 | 33,936,491 | 33,939,023 | RGD:2290271 | ENSEMBL | ||
| G | S1PR1 | sphingosine-1-phosphate receptor 1 |
|
IEA | 1 | 101,702,305 | 101,707,076 | RGD:2290271 | ENSEMBL | ||
| G | TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) |
|
IEA | 20 | 36,756,863 | 36,793,700 | RGD:2290271 | ENSEMBL | ||
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADAM17 | ADAM metallopeptidase domain 17 |
|
IMP | 2 | 9,629,392 | 9,695,917 | RGD:2290271 | BHF-UCL | ||
| G | ADRA2A | adrenoceptor alpha 2A |
|
IDA | 10 | 112,836,790 | 112,840,665 | RGD:2290271 | BHF-UCL | ||
| G | ADRA2A | adrenoceptor alpha 2A |
|
IDA | 10 | 112,836,790 | 112,840,665 | RGD:2290271 | BHF-UCL | ||
| G | ADRA2B | adrenoceptor alpha 2B |
|
IDA | 2 | 96,778,623 | 96,781,888 | RGD:2290271 | BHF-UCL | ||
| G | ADRA2C | adrenoceptor alpha 2C |
|
IDA | 4 | 3,768,296 | 3,770,253 | RGD:2290271 | BHF-UCL | ||
G-protein coupled acetylcholine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRBK1 | adrenergic, beta, receptor kinase 1 |
|
ISS | 11 | 67,033,905 | 67,054,029 | RGD:2290271 | BHF-UCL | ||
| G | AGRN | agrin |
|
TAS | 1 | 955,503 | 991,499 | RGD:2290271 | UniProtKB | ||
| G | CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
ISS | 17 | 30,814,105 | 30,818,271 | RGD:2290271 | UniProtKB | ||
| G | CHRM1 | cholinergic receptor, muscarinic 1 |
|
TAS | 11 | 62,676,151 | 62,689,012 | RGD:2290271 | PINC | ||
| G | CHRM4 | cholinergic receptor, muscarinic 4 |
|
TAS | 11 | 46,406,640 | 46,408,107 | RGD:2290271 | PINC | ||
| G | CHRM5 | cholinergic receptor, muscarinic 5 |
|
TAS | 15 | 34,261,089 | 34,357,287 | RGD:2290271 | PINC | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
IEA | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | ENSEMBL | ||
| G | GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
TAS | 1 | 1,716,725 | 1,822,526 | RGD:2290271 | PINC | ||
| G | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) |
|
ISS | 20 | 8,113,296 | 8,865,547 | RGD:2290271 | BHF-UCL | ||
G-protein coupled glutamate receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GRIK3 | glutamate receptor, ionotropic, kainate 3 |
|
IDA | 1 | 37,261,128 | 37,499,844 | RGD:2290271 | UniProtKB | ||
| G | GRM6 | glutamate receptor, metabotropic 6 |
|
TAS | 5 | 178,405,328 | 178,422,124 | RGD:2290271 | PINC | ||
| G | HOMER2 | homer homolog 2 (Drosophila) |
|
TAS | 15 | 83,517,729 | 83,621,476 | RGD:2290271 | PINC | ||
| G | HOMER3 | homer homolog 3 (Drosophila) |
|
TAS | 19 | 19,040,010 | 19,052,041 | RGD:2290271 | PINC | ||
G-protein coupled receptor internalization
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADM | adrenomedullin |
|
IDA | 11 | 10,326,642 | 10,328,923 | RGD:2290271 | UniProtKB | ||
| G | ARRB1 | arrestin, beta 1 |
|
IMP | 11 | 74,971,166 | 75,062,875 | RGD:2290271 | UniProtKB | ||
| G | ARRB1 | arrestin, beta 1 |
|
IMP | 11 | 74,971,166 | 75,062,875 | RGD:2290271 | UniProtKB | ||
| G | ARRB2 | arrestin, beta 2 |
|
IDA | 17 | 4,613,789 | 4,624,795 | RGD:2290271 | UniProtKB | ||
| G | ARRB2 | arrestin, beta 2 |
|
IMP | 17 | 4,613,789 | 4,624,795 | RGD:2290271 | UniProtKB | ||
| G | CALCA | calcitonin-related polypeptide alpha |
|
IDA | 11 | 14,988,215 | 14,993,832 | RGD:2290271 | UniProtKB | ||
| G | DRD2 | dopamine receptor D2 |
|
IEA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | ENSEMBL | ||
| G | DRD3 | dopamine receptor D3 |
|
IDA | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | BHF-UCL | ||
| G | GRK4 | G protein-coupled receptor kinase 4 |
|
IEA | 4 | 2,965,343 | 3,042,474 | RGD:2290271 | ENSEMBL | ||
| G | GTF2H2 | general transcription factor IIH, polypeptide 2, 44kDa |
|
IMP | 5 | 70,330,951 | 70,363,497 | RGD:2290271 | UniProtKB | ||
| G | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
IEA | 6 | 78,171,948 | 78,173,120 | RGD:2290271 | ENSEMBL | ||
| G | HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
IMP | 2 | 231,972,947 | 231,989,824 | RGD:2290271 | UniProtKB | ||
| G | PLD2 | phospholipase D2 |
|
IEA | 17 | 4,710,396 | 4,726,727 | RGD:2290271 | ENSEMBL | ||
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
TAS | 1 | 230,838,269 | 230,850,336 | RGD:2290271 | BHF-UCL | ||
| G | AGTR2 | angiotensin II receptor, type 2 |
|
ISS | X | 115,301,958 | 115,306,225 | RGD:2290271 | BHF-UCL | ||
| G | FZD1 | frizzled family receptor 1 |
|
IBA | 7 | 90,893,783 | 90,898,132 | RGD:2290271 | RefGenome | ||
| G | FZD2 | frizzled family receptor 2 |
|
IBA | 17 | 42,634,812 | 42,638,630 | RGD:2290271 | RefGenome | ||
| G | FZD3 | frizzled family receptor 3 |
|
IBA | 8 | 28,351,722 | 28,431,785 | RGD:2290271 | RefGenome | ||
| G | FZD6 | frizzled family receptor 6 |
|
IBA | 8 | 104,310,661 | 104,345,094 | RGD:2290271 | RefGenome | ||
| G | FZD7 | frizzled family receptor 7 |
|
IBA | 2 | 202,899,310 | 202,903,160 | RGD:2290271 | RefGenome | ||
| G | TBL3 | transducin (beta)-like 3 |
|
TAS | 16 | 2,022,064 | 2,028,751 | RGD:2290271 | PINC | ||
G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRB3 | adrenoceptor beta 3 |
|
TAS | 8 | 37,820,513 | 37,824,184 | RGD:2290271 | PINC | ||
| G | CALCRL | calcitonin receptor-like |
|
TAS | 2 | 188,207,846 | 188,313,021 | RGD:2290271 | PINC | ||
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
TAS | 17 | 32,582,296 | 32,584,222 | RGD:2290271 | PINC | ||
| G | CCR1 | chemokine (C-C motif) receptor 1 |
|
TAS | 3 | 46,243,200 | 46,249,832 | RGD:2290271 | PINC | ||
| G | CHRM2 | cholinergic receptor, muscarinic 2 |
|
TAS | 7 | 136,553,399 | 136,701,771 | RGD:2290271 | PINC | ||
| G | CNR1 | cannabinoid receptor 1 (brain) |
|
TAS | 6 | 88,849,583 | 88,875,767 | RGD:2290271 | PINC | ||
| G | CNR2 | cannabinoid receptor 2 (macrophage) |
|
TAS | 1 | 24,200,460 | 24,239,817 | RGD:2290271 | PINC | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | BHF-UCL | ||
| G | HRH2 | histamine receptor H2 |
|
TAS | 5 | 175,085,040 | 175,113,245 | RGD:2290271 | PINC | ||
| G | HRH3 | histamine receptor H3 |
|
TAS | 20 | 60,790,017 | 60,795,323 | RGD:2290271 | PINC | ||
| G | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
TAS | 6 | 78,171,948 | 78,173,120 | RGD:2290271 | PINC | ||
| G | HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
|
TAS | 1 | 23,518,388 | 23,521,222 | RGD:2290271 | PINC | ||
| G | HTR1E | 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
|
TAS | 6 | 87,647,024 | 87,726,397 | RGD:2290271 | PINC | ||
| G | HTR1F | 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
|
TAS | 3 | 88,031,726 | 88,042,919 | RGD:2290271 | PINC | ||
| G | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
TAS | 5 | 147,830,595 | 148,033,739 | RGD:2290271 | PINC | ||
| G | HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
IEA | 7 | 154,862,034 | 154,879,102 | RGD:2290271 | ENSEMBL | ||
| G | HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
IEA | 1 | 19,991,780 | 20,006,055 | RGD:2290271 | ENSEMBL | ||
| G | HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
TAS | 10 | 92,500,575 | 92,617,671 | RGD:2290271 | PINC | ||
| G | LHCGR | luteinizing hormone/choriogonadotropin receptor |
|
TAS | 2 | 48,913,913 | 48,982,880 | RGD:2290271 | PINC | ||
| G | LPAR3 | lysophosphatidic acid receptor 3 |
|
TAS | 1 | 85,279,086 | 85,358,896 | RGD:2290271 | PINC | ||
| G | MC1R | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
|
TAS | 16 | 89,984,287 | 89,987,385 | RGD:2290271 | PINC | ||
| G | MC2R | melanocortin 2 receptor (adrenocorticotropic hormone) |
|
TAS | 18 | 13,882,043 | 13,915,535 | RGD:2290271 | PINC | ||
| G | MC3R | melanocortin 3 receptor |
|
TAS | 20 | 54,823,788 | 54,824,871 | RGD:2290271 | PINC | ||
| G | MC5R | melanocortin 5 receptor |
|
TAS | 18 | 13,825,543 | 13,826,861 | RGD:2290271 | PINC | ||
| G | MTNR1A | melatonin receptor 1A |
|
TAS | 4 | 187,454,809 | 187,476,537 | RGD:2290271 | PINC | ||
| G | MTNR1B | melatonin receptor 1B |
|
TAS | 11 | 92,702,789 | 92,715,948 | RGD:2290271 | PINC | ||
| G | NPY | neuropeptide Y |
|
TAS | 7 | 24,323,807 | 24,331,484 | RGD:2290271 | PINC | ||
| G | NPY1R | neuropeptide Y receptor Y1 |
|
TAS | 4 | 164,245,117 | 164,253,947 | RGD:2290271 | PINC | ||
| G | OPRD1 | opioid receptor, delta 1 |
|
TAS | 1 | 29,138,654 | 29,190,208 | RGD:2290271 | PINC | ||
| G | OPRM1 | opioid receptor, mu 1 |
|
TAS | 6 | 154,331,631 | 154,568,001 | RGD:2290271 | PINC | ||
| G | PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) |
|
TAS | 19 | 47,123,725 | 47,128,354 | RGD:2290271 | PINC | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
TAS | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | PINC | ||
| G | SSTR1 | somatostatin receptor 1 |
|
TAS | 14 | 38,677,204 | 38,682,268 | RGD:2290271 | PINC | ||
| G | SSTR2 | somatostatin receptor 2 |
|
TAS | 17 | 71,161,160 | 71,168,094 | RGD:2290271 | PINC | ||
| G | SSTR3 | somatostatin receptor 3 |
|
TAS | 22 | 37,602,245 | 37,608,353 | RGD:2290271 | PINC | ||
| G | SSTR4 | somatostatin receptor 4 |
|
TAS | 20 | 23,016,057 | 23,017,314 | RGD:2290271 | PINC | ||
| G | SSTR5 | somatostatin receptor 5 |
|
TAS | 16 | 1,122,756 | 1,131,454 | RGD:2290271 | PINC | ||
| G | TSHR | thyroid stimulating hormone receptor |
|
TAS | 14 | 81,421,869 | 81,612,646 | RGD:2290271 | PINC | ||
| G | VIPR1 | vasoactive intestinal peptide receptor 1 |
|
TAS | 3 | 42,530,791 | 42,579,065 | RGD:2290271 | PINC | ||
| G | XCR1 | chemokine (C motif) receptor 1 |
|
TAS | 3 | 46,062,291 | 46,068,979 | RGD:2290271 | PINC | ||
gamma-aminobutyric acid signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) |
|
IEA | 22 | 39,916,569 | 39,918,691 | RGD:2290271 | ENSEMBL | ||
| G | CACNB4 | calcium channel, voltage-dependent, beta 4 subunit |
|
IEA | 2 | 152,689,285 | 152,955,593 | RGD:2290271 | ENSEMBL | ||
| G | GABBR1 | gamma-aminobutyric acid (GABA) B receptor, 1 |
|
IEA | 6 | 29,570,005 | 29,600,962 | RGD:2290271 | ENSEMBL | ||
| G | GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 |
|
IEA | 9 | 101,050,364 | 101,471,479 | RGD:2290271 | ENSEMBL | ||
| G | GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
IEA | 5 | 161,274,197 | 161,326,965 | RGD:2290271 | InterPro | ||
| G | GABRA2 | gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
IMP | 4 | 46,251,575 | 46,392,056 | RGD:2290271 | UniProtKB | ||
| G | GABRA2 | gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
IEA | 4 | 46,251,575 | 46,392,056 | RGD:2290271 | InterPro | ||
| G | GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
|
IEA | X | 151,335,634 | 151,619,831 | RGD:2290271 | InterPro | ||
| G | GABRA4 | gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
|
IEA | 4 | 46,920,917 | 46,996,424 | RGD:2290271 | InterPro | ||
| G | GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
|
IEA | 15 | 27,111,866 | 27,194,357 | RGD:2290271 | InterPro | ||
| G | GABRA6 | gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
|
IEA | 5 | 161,112,658 | 161,129,598 | RGD:2290271 | InterPro | ||
| G | GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
TAS | 5 | 160,715,436 | 160,975,130 | RGD:2290271 | PINC | ||
| G | GABRE | gamma-aminobutyric acid (GABA) A receptor, epsilon |
|
TAS | X | 151,121,596 | 151,143,151 | RGD:2290271 | PINC | ||
| G | GABRE | gamma-aminobutyric acid (GABA) A receptor, epsilon |
|
IEA | X | 151,121,596 | 151,143,151 | RGD:2290271 | InterPro | ||
| G | GABRG1 | gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
|
IEA | 4 | 46,037,786 | 46,126,082 | RGD:2290271 | InterPro | ||
| G | GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
IEA | 5 | 161,494,648 | 161,582,545 | RGD:2290271 | ENSEMBL | ||
| G | GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
IEA | 5 | 161,494,648 | 161,582,545 | RGD:2290271 | InterPro | ||
| G | GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
IEA | 5 | 161,494,648 | 161,582,545 | RGD:2290271 | InterPro | ||
| G | GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
IEA | 5 | 161,494,648 | 161,582,545 | RGD:2290271 | InterPro | ||
| G | GABRG3 | gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
|
IEA | 15 | 27,216,429 | 27,778,373 | RGD:2290271 | InterPro | ||
| G | GABRG3 | gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
|
IEA | 15 | 27,216,429 | 27,778,373 | RGD:2290271 | InterPro | ||
| G | GABRG3 | gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
|
IEA | 15 | 27,216,429 | 27,778,373 | RGD:2290271 | InterPro | ||
| G | GABRR1 | gamma-aminobutyric acid (GABA) A receptor, rho 1 |
|
TAS | 6 | 89,887,223 | 89,941,007 | RGD:2290271 | PINC | ||
| G | GABRR3 | gamma-aminobutyric acid (GABA) A receptor, rho 3 |
|
NAS | 3 | 97,705,527 | 97,754,148 | RGD:2290271 | UniProtKB | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
IBA | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | RefGenome | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
IEA | 3 | 50,273,647 | 50,296,786 | RGD:2290271 | ENSEMBL | ||
inhibitory G-protein coupled receptor phosphorylation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CAMK2B | calcium/calmodulin-dependent protein kinase II beta |
|
IEA | 7 | 44,256,749 | 44,365,230 | RGD:2290271 | ENSEMBL | ||
negative regulation of adenosine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADA | adenosine deaminase |
|
IDA | 20 | 43,248,163 | 43,280,376 | RGD:2290271 | UniProtKB | ||
negative regulation of adrenergic receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRA2A | adrenoceptor alpha 2A |
|
ISS | 10 | 112,836,790 | 112,840,665 | RGD:2290271 | BHF-UCL | ||
negative regulation of dopamine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | DRD2 | dopamine receptor D2 |
|
ISS | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | BHF-UCL | ||
| G | DRD2 | dopamine receptor D2 |
|
IEA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | ENSEMBL | ||
| G | DRD3 | dopamine receptor D3 |
|
IEA | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | ENSEMBL | ||
| G | PALM | paralemmin |
|
IDA | 19 | 708,953 | 748,330 | RGD:2290271 | UniProtKB | ||
negative regulation of G-protein coupled receptor protein signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CCL5 | chemokine (C-C motif) ligand 5 |
|
IDA | 17 | 34,198,495 | 34,207,377 | RGD:2290271 | UniProtKB | ||
| G | IL8 | interleukin 8 |
|
IDA | 4 | 74,606,223 | 74,609,433 | RGD:2290271 | UniProtKB | ||
| G | KLK14 | kallikrein-related peptidase 14 |
|
IDA | 19 | 51,581,154 | 51,587,502 | RGD:2290271 | UniProtKB | ||
| G | MGRN1 | mahogunin ring finger 1, E3 ubiquitin protein ligase |
|
IDA | 16 | 4,674,825 | 4,740,975 | RGD:2290271 | UniProtKB | ||
| G | PLEK | pleckstrin |
|
IDA | 2 | 68,592,322 | 68,624,585 | RGD:2290271 | BHF-UCL | ||
| G | RGS2 | regulator of G-protein signaling 2, 24kDa |
|
ISS | 1 | 192,778,169 | 192,781,407 | RGD:2290271 | BHF-UCL | ||
| G | RPGRIP1L | RPGRIP1-like |
|
IDA | 16 | 53,633,818 | 53,737,771 | RGD:2290271 | UniProtKB | ||
| G | RPH3AL | rabphilin 3A-like (without C2 domains) |
|
IEA | 17 | 62,180 | 202,633 | RGD:2290271 | ENSEMBL | ||
negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BICD1 | bicaudal D homolog 1 (Drosophila) |
|
ISS | 12 | 32,260,185 | 32,531,141 | RGD:2290271 | BHF-UCL | ||
negative regulation of thrombin receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | SNCA | synuclein, alpha (non A4 component of amyloid precursor) |
|
IDA | 4 | 90,645,250 | 90,759,447 | RGD:2290271 | UniProtKB | ||
neuropeptide signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AGRP | agouti related protein homolog (mouse) |
|
IDA | 16 | 67,516,474 | 67,517,716 | RGD:2290271 | UniProtKB | ||
| G | BAI1 | brain-specific angiogenesis inhibitor 1 |
|
IEA | 8 | 143,545,377 | 143,626,368 | RGD:2290271 | InterPro | ||
| G | BAI2 | brain-specific angiogenesis inhibitor 2 |
|
IEA | 1 | 32,192,718 | 32,229,648 | RGD:2290271 | InterPro | ||
| G | BAI3 | brain-specific angiogenesis inhibitor 3 |
|
IEA | 6 | 69,345,632 | 70,099,403 | RGD:2290271 | InterPro | ||
| G | CALCA | calcitonin-related polypeptide alpha |
|
IEA | 11 | 14,988,215 | 14,993,832 | RGD:2290271 | ENSEMBL | ||
| G | CARTPT | CART prepropeptide |
|
IEA | 5 | 71,014,990 | 71,016,875 | RGD:2290271 | UniProtKB | ||
| G | CD97 | CD97 molecule |
|
IEA | 19 | 14,491,956 | 14,519,537 | RGD:2290271 | InterPro | ||
| G | CELSR1 | cadherin, EGF LAG seven-pass G-type receptor 1 |
|
IEA | 22 | 46,756,731 | 46,933,067 | RGD:2290271 | InterPro | ||
| G | CELSR2 | cadherin, EGF LAG seven-pass G-type receptor 2 |
|
IEA | 1 | 109,792,641 | 109,818,378 | RGD:2290271 | InterPro | ||
| G | CELSR3 | cadherin, EGF LAG seven-pass G-type receptor 3 |
|
IEA | 3 | 48,673,896 | 48,700,348 | RGD:2290271 | InterPro | ||
| G | CPE | carboxypeptidase E |
|
NAS | 4 | 166,300,097 | 166,419,482 | RGD:2290271 | UniProtKB | ||
| G | CRCP | CGRP receptor component |
|
IEA | 7 | 65,579,805 | 65,619,555 | RGD:2290271 | ENSEMBL | ||
| G | CRHR1 | corticotropin releasing hormone receptor 1 |
|
IEA | 17 | 43,697,710 | 43,913,194 | RGD:2290271 | ENSEMBL | ||
| G | ECEL1 | endothelin converting enzyme-like 1 |
|
TAS | 2 | 233,344,537 | 233,352,532 | RGD:2290271 | PINC | ||
| G | ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 |
|
IEA | 1 | 79,355,449 | 79,472,495 | RGD:2290271 | InterPro | ||
| G | EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 |
|
IEA | 19 | 6,887,560 | 6,940,464 | RGD:2290271 | InterPro | ||
| G | EMR2 | egf-like module containing, mucin-like, hormone receptor-like 2 |
|
IEA | 19 | 14,843,509 | 14,889,353 | RGD:2290271 | InterPro | ||
| G | EMR3 | egf-like module containing, mucin-like, hormone receptor-like 3 |
|
IEA | 19 | 14,730,051 | 14,785,730 | RGD:2290271 | InterPro | ||
| G | EMR4P | egf-like module containing, mucin-like, hormone receptor-like 4 pseudogene |
|
IEA | 19 | 6,952,511 | 6,990,857 | RGD:2290271 | InterPro | ||
| G | GAL | galanin/GMAP prepropeptide |
|
IEA | 11 | 68,451,983 | 68,458,643 | RGD:2290271 | ENSEMBL | ||
| G | GALP | galanin-like peptide |
|
IEA | 19 | 56,687,389 | 56,697,144 | RGD:2290271 | UniProtKB | ||
| G | GALR1 | galanin receptor 1 |
|
TAS | 18 | 74,962,008 | 74,982,098 | RGD:2290271 | PINC | ||
| G | GALR3 | galanin receptor 3 |
|
TAS | 22 | 38,219,389 | 38,221,502 | RGD:2290271 | PINC | ||
| G | GLRA1 | glycine receptor, alpha 1 |
|
IDA | 5 | 151,202,074 | 151,304,397 | RGD:2290271 | UniProtKB | ||
| G | GLRA2 | glycine receptor, alpha 2 |
|
IDA | X | 14,547,420 | 14,749,934 | RGD:2290271 | UniProtKB | ||
| G | GLRB | glycine receptor, beta |
|
IDA | 4 | 157,997,277 | 158,093,242 | RGD:2290271 | UniProtKB | ||
| G | GPR110 | G protein-coupled receptor 110 |
|
IEA | 6 | 46,967,813 | 47,010,082 | RGD:2290271 | InterPro | ||
| G | GPR111 | G protein-coupled receptor 111 |
|
IEA | 6 | 47,624,326 | 47,665,533 | RGD:2290271 | InterPro | ||
| G | GPR112 | G protein-coupled receptor 112 |
|
IEA | X | 135,383,122 | 135,499,047 | RGD:2290271 | InterPro | ||
| G | GPR113 | G protein-coupled receptor 113 |
|
IEA | 2 | 26,531,041 | 26,569,685 | RGD:2290271 | InterPro | ||
| G | GPR114 | G protein-coupled receptor 114 |
|
IEA | 16 | 57,576,601 | 57,611,101 | RGD:2290271 | InterPro | ||
| G | GPR115 | G protein-coupled receptor 115 |
|
IEA | 6 | 47,666,289 | 47,689,757 | RGD:2290271 | InterPro | ||
| G | GPR116 | G protein-coupled receptor 116 |
|
IEA | 6 | 46,820,242 | 46,922,675 | RGD:2290271 | InterPro | ||
| G | GPR124 | G protein-coupled receptor 124 |
|
IEA | 8 | 37,654,401 | 37,701,504 | RGD:2290271 | InterPro | ||
| G | GPR125 | G protein-coupled receptor 125 |
|
IEA | 4 | 22,388,997 | 22,517,677 | RGD:2290271 | InterPro | ||
| G | GPR126 | G protein-coupled receptor 126 |
|
IEA | 6 | 142,623,056 | 142,767,403 | RGD:2290271 | InterPro | ||
| G | GPR128 | G protein-coupled receptor 128 |
|
IEA | 3 | 100,328,433 | 100,414,323 | RGD:2290271 | InterPro | ||
| G | GPR133 | G protein-coupled receptor 133 |
|
IEA | 12 | 131,438,452 | 131,626,010 | RGD:2290271 | InterPro | ||
| G | GPR144 | G protein-coupled receptor 144 |
|
IEA | 9 | 127,213,423 | 127,239,379 | RGD:2290271 | InterPro | ||
| G | GPR56 | G protein-coupled receptor 56 |
|
IEA | 16 | 57,653,910 | 57,698,944 | RGD:2290271 | InterPro | ||
| G | GPR64 | G protein-coupled receptor 64 |
|
IEA | X | 19,007,425 | 19,140,755 | RGD:2290271 | InterPro | ||
| G | GPR97 | G protein-coupled receptor 97 |
|
IEA | 16 | 57,702,157 | 57,723,290 | RGD:2290271 | InterPro | ||
| G | GPR98 | G protein-coupled receptor 98 |
|
IEA | 5 | 89,854,617 | 90,460,033 | RGD:2290271 | InterPro | ||
| G | GRP | gastrin-releasing peptide |
|
IDA | 18 | 56,887,400 | 56,898,003 | RGD:2290271 | MGI | ||
| G | HCRT | hypocretin (orexin) neuropeptide precursor |
|
IEA | 17 | 40,336,078 | 40,337,470 | RGD:2290271 | UniProtKB | ||
| G | HCRTR1 | hypocretin (orexin) receptor 1 |
|
IEA | 1 | 32,083,301 | 32,092,919 | RGD:2290271 | ENSEMBL | ||
| G | HCRTR2 | hypocretin (orexin) receptor 2 |
|
TAS | 6 | 55,039,071 | 55,147,418 | RGD:2290271 | PINC | ||
| G | KISS1R | KISS1 receptor |
|
IDA | 19 | 917,342 | 921,015 | RGD:2290271 | GOC | ||
| G | LPHN1 | latrophilin 1 |
|
IEA | 19 | 14,258,549 | 14,316,997 | RGD:2290271 | InterPro | ||
| G | LPHN2 | latrophilin 2 |
|
IEA | 1 | 82,266,082 | 82,458,107 | RGD:2290271 | InterPro | ||
| G | LPHN3 | latrophilin 3 |
|
IEA | 4 | 62,362,839 | 62,938,168 | RGD:2290271 | InterPro | ||
| G | MCHR1 | melanin-concentrating hormone receptor 1 |
|
IEA | 22 | 41,075,182 | 41,078,818 | RGD:2290271 | InterPro | ||
| G | NMB | neuromedin B |
|
IEA | 15 | 85,198,360 | 85,201,802 | RGD:2290271 | InterPro | ||
| G | NMS | neuromedin S |
|
IEA | 2 | 101,086,944 | 101,099,742 | RGD:2290271 | UniProtKB | ||
| G | NMU | neuromedin U |
|
IEA | 4 | 56,461,398 | 56,502,465 | RGD:2290271 | ENSEMBL | ||
| G | NMUR1 | neuromedin U receptor 1 |
|
TAS | 2 | 232,387,871 | 232,395,182 | RGD:2290271 | UniProtKB | ||
| G | NMUR2 | neuromedin U receptor 2 |
|
TAS | 5 | 151,771,102 | 151,784,840 | RGD:2290271 | PINC | ||
| G | NPB | neuropeptide B |
|
IEA | 17 | 79,860,072 | 79,860,781 | RGD:2290271 | UniProtKB | ||
| G | NPFF | neuropeptide FF-amide peptide precursor |
|
IEA | 12 | 53,900,474 | 53,901,422 | RGD:2290271 | UniProtKB | ||
| G | NPFFR1 | neuropeptide FF receptor 1 |
|
NAS | 10 | 72,014,713 | 72,043,450 | RGD:2290271 | GOC | ||
| G | NPIPP1 | nuclear pore complex interacting protein pseudogene 1 |
|
IEA | 16 | 15,198,155 | 15,217,355 | RGD:2290271 | InterPro | ||
| G | NPS | neuropeptide S |
|
IEA | 10 | 129,347,613 | 129,350,935 | RGD:2290271 | UniProtKB | ||
| G | NPVF | neuropeptide VF precursor |
|
NAS | 7 | 25,264,189 | 25,268,105 | RGD:2290271 | UniProtKB | ||
| G | NPW | neuropeptide W |
|
IEA | 16 | 2,069,521 | 2,070,756 | RGD:2290271 | UniProtKB | ||
| G | NPY | neuropeptide Y |
|
IEA | 7 | 24,323,807 | 24,331,484 | RGD:2290271 | UniProtKB | ||
| G | NXPH2 | neurexophilin 2 |
|
NAS | 2 | 139,426,727 | 139,537,811 | RGD:2290271 | UniProtKB | ||
| G | NXPH3 | neurexophilin 3 |
|
NAS | 17 | 47,653,298 | 47,661,172 | RGD:2290271 | UniProtKB | ||
| G | NXPH4 | neurexophilin 4 |
|
NAS | 12 | 57,610,578 | 57,620,232 | RGD:2290271 | UniProtKB | ||
| G | OPRD1 | opioid receptor, delta 1 |
|
IEA | 1 | 29,138,654 | 29,190,208 | RGD:2290271 | ENSEMBL | ||
| G | PCSK1N | proprotein convertase subtilisin/kexin type 1 inhibitor |
|
IEA | X | 48,689,506 | 48,693,960 | RGD:2290271 | UniProtKB | ||
| G | PDYN | prodynorphin |
|
IEA | 20 | 1,959,402 | 1,974,931 | RGD:2290271 | UniProtKB | ||
| G | PDYN | prodynorphin |
|
IEA | 20 | 1,959,402 | 1,974,931 | RGD:2290271 | UniProtKB | ||
| G | PENK | proenkephalin |
|
IEA | 8 | 57,353,513 | 57,359,282 | RGD:2290271 | UniProtKB | ||
| G | PENK | proenkephalin |
|
IEA | 8 | 57,353,513 | 57,359,282 | RGD:2290271 | UniProtKB | ||
| G | PENK | proenkephalin |
|
IEA | 8 | 57,353,513 | 57,359,282 | RGD:2290271 | InterPro | ||
| G | PENK | proenkephalin |
|
IEA | 8 | 57,353,513 | 57,359,282 | RGD:2290271 | UniProtKB | ||
| G | PKD1 | polycystic kidney disease 1 (autosomal dominant) |
|
IEA | 16 | 2,138,711 | 2,185,899 | RGD:2290271 | InterPro | ||
| G | PKD1L2 | polycystic kidney disease 1-like 2 |
|
IEA | 16 | 81,134,484 | 81,253,975 | RGD:2290271 | InterPro | ||
| G | PKD1L3 | polycystic kidney disease 1-like 3 |
|
IEA | 16 | 71,963,441 | 72,033,877 | RGD:2290271 | InterPro | ||
| G | PKDREJ | polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin) |
|
IEA | 22 | 46,651,560 | 46,659,219 | RGD:2290271 | InterPro | ||
| G | PMCH | pro-melanin-concentrating hormone |
|
IEA | 12 | 102,590,237 | 102,591,614 | RGD:2290271 | UniProtKB | ||
| G | PNOC | prepronociceptin |
|
IEA | 8 | 28,174,649 | 28,200,868 | RGD:2290271 | ENSEMBL | ||
| G | POMC | proopiomelanocortin |
|
IEA | 2 | 25,383,722 | 25,391,559 | RGD:2290271 | UniProtKB | ||
| G | PRLHR | prolactin releasing hormone receptor |
|
TAS | 10 | 120,352,916 | 120,355,160 | RGD:2290271 | GOC | ||
| G | PROK2 | prokineticin 2 |
|
IEA | 3 | 71,820,806 | 71,834,357 | RGD:2290271 | UniProtKB | ||
| G | PTH2 | parathyroid hormone 2 |
|
IEA | 19 | 49,925,671 | 49,926,698 | RGD:2290271 | UniProtKB | ||
| G | QRFP | pyroglutamylated RFamide peptide |
|
IDA | 9 | 133,768,815 | 133,769,225 | RGD:2290271 | UniProtKB | ||
| G | SCG5 | secretogranin V (7B2 protein) |
|
IEA | 15 | 32,933,870 | 32,989,298 | RGD:2290271 | UniProtKB | ||
| G | SCG5 | secretogranin V (7B2 protein) |
|
IEA | 15 | 32,933,870 | 32,989,298 | RGD:2290271 | InterPro | ||
| G | SORCS1 | sortilin-related VPS10 domain containing receptor 1 |
|
NAS | 10 | 108,333,421 | 108,924,466 | RGD:2290271 | UniProtKB | ||
| G | SORCS2 | sortilin-related VPS10 domain containing receptor 2 |
|
NAS | 4 | 7,194,374 | 7,744,564 | RGD:2290271 | UniProtKB | ||
| G | SORCS3 | sortilin-related VPS10 domain containing receptor 3 |
|
NAS | 10 | 106,400,859 | 107,024,993 | RGD:2290271 | UniProtKB | ||
| G | SORT1 | sortilin 1 |
|
IDA | 1 | 109,852,187 | 109,940,563 | RGD:2290271 | BHF-UCL | ||
| G | TAC1 | tachykinin, precursor 1 |
|
IEA | 7 | 97,361,271 | 97,369,784 | RGD:2290271 | UniProtKB | ||
| G | TAC3 | tachykinin 3 |
|
IEA | 12 | 57,403,781 | 57,410,344 | RGD:2290271 | UniProtKB | ||
| G | TENM1 | teneurin transmembrane protein 1 |
|
IEA | X | 123,509,753 | 124,097,666 | RGD:2290271 | UniProtKB | ||
| G | UCN | urocortin |
|
IEA | 2 | 27,530,265 | 27,531,130 | RGD:2290271 | ENSEMBL | ||
opioid receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | NPBWR1 | neuropeptides B/W receptor 1 |
|
TAS | 8 | 53,852,468 | 53,853,454 | RGD:2290271 | GOC | ||
| G | NPBWR2 | neuropeptides B/W receptor 2 |
|
TAS | 20 | 62,737,183 | 62,738,184 | RGD:2290271 | GOC | ||
| G | OGFR | opioid growth factor receptor |
|
NAS | 20 | 61,436,177 | 61,445,352 | RGD:2290271 | GOC | ||
| G | OPCML | opioid binding protein/cell adhesion molecule-like |
|
TAS | 11 | 132,284,875 | 133,402,403 | RGD:2290271 | GOC | ||
| G | OPRD1 | opioid receptor, delta 1 |
|
IMP | 1 | 29,138,654 | 29,190,208 | RGD:2290271 | UniProtKB | ||
| G | OPRK1 | opioid receptor, kappa 1 |
|
IDA | 8 | 54,138,276 | 54,164,194 | RGD:2290271 | UniProtKB | ||
phospholipase C-activating adrenergic receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRA2A | adrenoceptor alpha 2A |
|
IDA | 10 | 112,836,790 | 112,840,665 | RGD:2290271 | BHF-UCL | ||
phospholipase C-activating angiotensin-mediated signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AGTR1 | angiotensin II receptor, type 1 |
|
IDA | 3 | 148,415,658 | 148,460,790 | RGD:2290271 | GOC | ||
| G | AGTR1 | angiotensin II receptor, type 1 |
|
IPI | 3 | 148,415,658 | 148,460,790 | RGD:2290271 | GOC | ||
phospholipase C-activating dopamine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | DRD1 | dopamine receptor D1 |
|
IDA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | BHF-UCL | ||
| G | DRD1 | dopamine receptor D1 |
|
IGI | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | MGI | ||
| G | DRD2 | dopamine receptor D2 |
|
IGI | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | MGI | ||
| G | DRD2 | dopamine receptor D2 |
|
IEA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | ENSEMBL | ||
| G | DRD5 | dopamine receptor D5 |
|
TAS | 4 | 9,783,258 | 9,785,633 | RGD:2290271 | BHF-UCL | ||
| G | GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
|
IBA | 19 | 3,094,408 | 3,121,468 | RGD:2290271 | RefGenome | ||
| G | GNA14 | guanine nucleotide binding protein (G protein), alpha 14 |
|
IBA | 9 | 80,037,995 | 80,263,232 | RGD:2290271 | RefGenome | ||
| G | GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
|
IBA | 19 | 3,136,191 | 3,163,766 | RGD:2290271 | RefGenome | ||
| G | GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
|
IEA | 9 | 80,335,189 | 80,646,219 | RGD:2290271 | ENSEMBL | ||
| G | GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
|
IBA | 9 | 80,335,189 | 80,646,219 | RGD:2290271 | RefGenome | ||
| G | SLC9A3R1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
IEA | 17 | 72,744,751 | 72,765,499 | RGD:2290271 | ENSEMBL | ||
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CHRM1 | cholinergic receptor, muscarinic 1 |
|
TAS | 11 | 62,676,151 | 62,689,012 | RGD:2290271 | PINC | ||
| G | CHRM2 | cholinergic receptor, muscarinic 2 |
|
TAS | 7 | 136,553,399 | 136,701,771 | RGD:2290271 | PINC | ||
| G | GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
|
TAS | 19 | 3,136,191 | 3,163,766 | RGD:2290271 | PINC | ||
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GRM5 | glutamate receptor, metabotropic 5 |
|
TAS | 11 | 88,237,744 | 88,796,816 | RGD:2290271 | PINC | ||
| G | HOMER1 | homer homolog 1 (Drosophila) |
|
TAS | 5 | 78,669,786 | 78,809,700 | RGD:2290271 | PINC | ||
phospholipase C-activating G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRA1A | adrenoceptor alpha 1A |
|
IEA | 8 | 26,605,667 | 26,722,922 | RGD:2290271 | ENSEMBL | ||
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
NAS | 1 | 230,838,269 | 230,850,336 | RGD:2290271 | BHF-UCL | ||
| G | AGTR1 | angiotensin II receptor, type 1 |
|
NAS | 3 | 148,415,658 | 148,460,790 | RGD:2290271 | BHF-UCL | ||
| G | CCKAR | cholecystokinin A receptor |
|
TAS | 4 | 26,483,018 | 26,492,042 | RGD:2290271 | PINC | ||
| G | CCKBR | cholecystokinin B receptor |
|
TAS | 11 | 6,280,904 | 6,293,357 | RGD:2290271 | PINC | ||
| G | CRHR1 | corticotropin releasing hormone receptor 1 |
|
IEA | 17 | 43,697,710 | 43,913,194 | RGD:2290271 | ENSEMBL | ||
| G | CXCR2 | chemokine (C-X-C motif) receptor 2 |
|
IDA | 2 | 218,990,013 | 219,001,976 | RGD:2290271 | UniProtKB | ||
| G | EDNRB | endothelin receptor type B |
|
IEA | 13 13 |
78,469,616 78,513,393 |
78,549,664 78,549,674 |
RGD:2290271 | ENSEMBL | ||
| G | F2R | coagulation factor II (thrombin) receptor |
|
IDA | 5 | 76,011,868 | 76,031,595 | RGD:2290271 | BHF-UCL | ||
| G | F2RL3 | coagulation factor II (thrombin) receptor-like 3 |
|
TAS | 19 | 16,999,826 | 17,002,830 | RGD:2290271 | PINC | ||
| G | GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
IEA | 1 | 1,716,725 | 1,822,526 | RGD:2290271 | ENSEMBL | ||
| G | GNG13 | guanine nucleotide binding protein (G protein), gamma 13 |
|
IEA | 16 | 848,041 | 850,733 | RGD:2290271 | ENSEMBL | ||
| G | GPR139 | G protein-coupled receptor 139 |
|
IEA | 16 | 20,043,043 | 20,085,100 | RGD:2290271 | ENSEMBL | ||
| G | HCRT | hypocretin (orexin) neuropeptide precursor |
|
IEA | 17 | 40,336,078 | 40,337,470 | RGD:2290271 | ENSEMBL | ||
| G | HCRTR2 | hypocretin (orexin) receptor 2 |
|
IEA | 6 | 55,039,071 | 55,147,418 | RGD:2290271 | ENSEMBL | ||
| G | HRH1 | histamine receptor H1 |
|
TAS | 3 | 11,178,779 | 11,304,939 | RGD:2290271 | PINC | ||
| G | LHCGR | luteinizing hormone/choriogonadotropin receptor |
|
ISS | 2 | 48,913,913 | 48,982,880 | RGD:2290271 | BHF-UCL | ||
| G | LTB4R | leukotriene B4 receptor |
|
TAS | 14 | 24,780,705 | 24,787,242 | RGD:2290271 | PINC | ||
| G | MC3R | melanocortin 3 receptor |
|
TAS | 20 | 54,823,788 | 54,824,871 | RGD:2290271 | PINC | ||
| G | NMBR | neuromedin B receptor |
|
TAS | 6 | 142,396,745 | 142,409,936 | RGD:2290271 | PINC | ||
| G | NMUR1 | neuromedin U receptor 1 |
|
IDA | 2 | 232,387,871 | 232,395,182 | RGD:2290271 | UniProtKB | ||
| G | NMUR2 | neuromedin U receptor 2 |
|
IDA | 5 | 151,771,102 | 151,784,840 | RGD:2290271 | UniProtKB | ||
| G | NPR3 | natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
IEA | 5 | 32,710,743 | 32,791,830 | RGD:2290271 | ENSEMBL | ||
| G | NTSR2 | neurotensin receptor 2 |
|
IEA | 2 | 11,798,304 | 11,810,329 | RGD:2290271 | ENSEMBL | ||
| G | OPRD1 | opioid receptor, delta 1 |
|
ISS | 1 | 29,138,654 | 29,190,208 | RGD:2290271 | UniProtKB | ||
| G | OPRK1 | opioid receptor, kappa 1 |
|
ISS | 8 | 54,138,276 | 54,164,194 | RGD:2290271 | UniProtKB | ||
| G | OPRK1 | opioid receptor, kappa 1 |
|
IEA | 8 | 54,138,276 | 54,164,194 | RGD:2290271 | ENSEMBL | ||
| G | OPRM1 | opioid receptor, mu 1 |
|
ISS | 6 | 154,331,631 | 154,568,001 | RGD:2290271 | UniProtKB | ||
| G | P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 |
|
TAS | 3 | 152,552,736 | 152,555,845 | RGD:2290271 | PINC | ||
| G | P2RY11 | purinergic receptor P2Y, G-protein coupled, 11 |
|
TAS | 19 | 10,222,197 | 10,226,065 | RGD:2290271 | PINC | ||
| G | P2RY2 | purinergic receptor P2Y, G-protein coupled, 2 |
|
TAS | 11 | 72,929,344 | 72,947,397 | RGD:2290271 | PINC | ||
| G | P2RY4 | pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
TAS | X | 69,478,016 | 69,479,654 | RGD:2290271 | PINC | ||
| G | P2RY6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 |
|
TAS | 11 | 72,975,570 | 73,009,664 | RGD:2290271 | PINC | ||
| G | PLCE1 | phospholipase C, epsilon 1 |
|
IDA | 10 | 95,753,746 | 96,088,149 | RGD:2290271 | UniProtKB | ||
| G | PTGER3 | prostaglandin E receptor 3 (subtype EP3) |
|
IEA | 1 | 71,318,036 | 71,513,491 | RGD:2290271 | ENSEMBL | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
IC | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | BHF-UCL | ||
| G | PTH1R | parathyroid hormone 1 receptor |
|
IEA | 3 | 46,919,236 | 46,945,289 | RGD:2290271 | ENSEMBL | ||
| G | TACR1 | tachykinin receptor 1 |
|
TAS | 2 | 75,273,590 | 75,426,645 | RGD:2290271 | PINC | ||
phospholipase C-activating serotonin receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
IEA | 13 | 47,405,677 | 47,471,211 | RGD:2290271 | ENSEMBL | ||
phospholipase C-inhibiting G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | PLEK | pleckstrin |
|
IDA | 2 | 68,592,322 | 68,624,585 | RGD:2290271 | BHF-UCL | ||
phospholipase D-activating G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | EDN1 | endothelin 1 |
|
IEA | 6 | 12,290,529 | 12,297,427 | RGD:2290271 | ENSEMBL | ||
positive regulation of adenosine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CNTN2 | contactin 2 (axonal) |
|
IEA | 1 | 205,012,340 | 205,047,171 | RGD:2290271 | ENSEMBL | ||
positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) |
|
IDA | 18 | 904,944 | 912,173 | RGD:2290271 | BHF-UCL | ||
| G | DRD1 | dopamine receptor D1 |
|
IEA | 5 | 174,867,675 | 174,871,163 | RGD:2290271 | InterPro | ||
| G | DRD5 | dopamine receptor D5 |
|
IEA | 4 | 9,783,258 | 9,785,633 | RGD:2290271 | InterPro | ||
| G | VIP | vasoactive intestinal peptide |
|
IDA | 6 | 153,071,932 | 153,080,900 | RGD:2290271 | BHF-UCL | ||
positive regulation of adrenergic receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ARRDC3 | arrestin domain containing 3 |
|
IEA | 5 | 90,664,541 | 90,679,149 | RGD:2290271 | ENSEMBL | ||
| G | GSK3A | glycogen synthase kinase 3 alpha |
|
ISS | 19 | 42,734,338 | 42,746,736 | RGD:2290271 | BHF-UCL | ||
positive regulation of dopamine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CAV2 | caveolin 2 |
|
IMP | 7 | 116,139,655 | 116,148,595 | RGD:2290271 | BHF-UCL | ||
| G | DRD3 | dopamine receptor D3 |
|
ISS | 3 | 113,847,557 | 113,897,899 | RGD:2290271 | BHF-UCL | ||
| G | LRRK2 | leucine-rich repeat kinase 2 |
|
IMP | 12 | 40,618,813 | 40,763,087 | RGD:2290271 | BHF-UCL | ||
positive regulation of G-protein coupled receptor protein signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | C3 | complement component 3 |
|
IDA | 19 | 6,677,846 | 6,720,662 | RGD:2290271 | UniProtKB | ||
| G | DRD2 | dopamine receptor D2 |
|
IEA | 11 | 113,280,317 | 113,346,001 | RGD:2290271 | ENSEMBL | ||
| G | KLK14 | kallikrein-related peptidase 14 |
|
IDA | 19 | 51,581,154 | 51,587,502 | RGD:2290271 | UniProtKB | ||
| G | KLK5 | kallikrein-related peptidase 5 |
|
IDA | 19 | 51,446,559 | 51,456,344 | RGD:2290271 | UniProtKB | ||
| G | KLK6 | kallikrein-related peptidase 6 |
|
IDA | 19 | 51,461,887 | 51,472,929 | RGD:2290271 | UniProtKB | ||
| G | PDE6G | phosphodiesterase 6G, cGMP-specific, rod, gamma |
|
IEA | 17 | 79,617,489 | 79,623,607 | RGD:2290271 | ENSEMBL | ||
| G | PDE6H | phosphodiesterase 6H, cGMP-specific, cone, gamma |
|
IEA | 12 | 15,125,956 | 15,134,799 | RGD:2290271 | ENSEMBL | ||
| G | PTGDR2 | prostaglandin D2 receptor 2 |
|
IEA | 11 | 60,618,398 | 60,623,444 | RGD:2290271 | ENSEMBL | ||
| G | TMOD2 | tropomodulin 2 (neuronal) |
|
IEA | 15 | 52,043,758 | 52,108,560 | RGD:2290271 | ENSEMBL | ||
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | F2 | coagulation factor II (thrombin) |
|
IDA | 11 | 46,740,743 | 46,761,056 | RGD:2290271 | BHF-UCL | ||
protein kinase C deactivation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | EDN1 | endothelin 1 |
|
IDA | 6 | 12,290,529 | 12,297,427 | RGD:2290271 | BHF-UCL | ||
protein kinase C-activating G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADORA2A | adenosine A2a receptor |
|
IEA | 22 | 24,823,530 | 24,838,325 | RGD:2290271 | ENSEMBL | ||
| G | AGK | acylglycerol kinase |
|
IEA | 7 | 141,251,078 | 141,354,209 | RGD:2290271 | InterPro | ||
| G | AZU1 | azurocidin 1 |
|
TAS | 19 | 827,831 | 832,017 | RGD:2290271 | UniProtKB | ||
| G | BDKRB1 | bradykinin receptor B1 |
|
IEA | 14 | 96,722,547 | 96,731,100 | RGD:2290271 | ENSEMBL | ||
| G | CCK | cholecystokinin |
|
IEA | 3 | 42,299,318 | 42,307,662 | RGD:2290271 | ENSEMBL | ||
| G | CERK | ceramide kinase |
|
IEA | 22 | 47,080,307 | 47,134,152 | RGD:2290271 | InterPro | ||
| G | CERKL | ceramide kinase-like |
|
IEA | 2 | 182,401,399 | 182,521,834 | RGD:2290271 | InterPro | ||
| G | CHRM1 | cholinergic receptor, muscarinic 1 |
|
TAS | 11 | 62,676,151 | 62,689,012 | RGD:2290271 | PINC | ||
| G | CISH | cytokine inducible SH2-containing protein |
|
IEA | 3 | 50,643,885 | 50,649,262 | RGD:2290271 | ENSEMBL | ||
| G | DGKA | diacylglycerol kinase, alpha 80kDa |
|
IEA | 12 | 56,324,946 | 56,347,807 | RGD:2290271 | InterPro | ||
| G | DGKB | diacylglycerol kinase, beta 90kDa |
|
IEA | 7 | 14,184,674 | 14,881,075 | RGD:2290271 | InterPro | ||
| G | DGKD | diacylglycerol kinase, delta 130kDa |
|
NAS | 2 | 234,263,153 | 234,380,743 | RGD:2290271 | UniProtKB | ||
| G | DGKD | diacylglycerol kinase, delta 130kDa |
|
IEA | 2 | 234,263,153 | 234,380,743 | RGD:2290271 | InterPro | ||
| G | DGKE | diacylglycerol kinase, epsilon 64kDa |
|
IEA | 17 | 54,911,460 | 54,946,036 | RGD:2290271 | InterPro | ||
| G | DGKG | diacylglycerol kinase, gamma 90kDa |
|
IEA | 3 | 185,864,990 | 186,080,023 | RGD:2290271 | InterPro | ||
| G | DGKH | diacylglycerol kinase, eta |
|
IMP | 13 | 42,614,172 | 42,803,891 | RGD:2290271 | UniProtKB | ||
| G | DGKH | diacylglycerol kinase, eta |
|
IEA | 13 | 42,614,172 | 42,803,891 | RGD:2290271 | InterPro | ||
| G | DGKI | diacylglycerol kinase, iota |
|
IEA | 7 | 137,074,385 | 137,531,609 | RGD:2290271 | InterPro | ||
| G | DGKK | diacylglycerol kinase, kappa |
|
IEA | X | 50,111,879 | 50,213,721 | RGD:2290271 | InterPro | ||
| G | DGKQ | diacylglycerol kinase, theta 110kDa |
|
IEA | 4 | 952,672 | 967,348 | RGD:2290271 | InterPro | ||
| G | DGKQ | diacylglycerol kinase, theta 110kDa |
|
IEA | 4 | 952,672 | 967,348 | RGD:2290271 | InterPro | ||
| G | DGKZ | diacylglycerol kinase, zeta |
|
IEA | 11 | 46,354,455 | 46,402,104 | RGD:2290271 | InterPro | ||
| G | DGKZ | diacylglycerol kinase, zeta |
|
IEA | 11 | 46,354,455 | 46,402,104 | RGD:2290271 | InterPro | ||
| G | EDN1 | endothelin 1 |
|
IEA | 6 | 12,290,529 | 12,297,427 | RGD:2290271 | ENSEMBL | ||
| G | EDNRA | endothelin receptor type A |
|
IEA | 4 | 148,402,069 | 148,466,106 | RGD:2290271 | ENSEMBL | ||
| G | F2R | coagulation factor II (thrombin) receptor |
|
ISS | 5 | 76,011,868 | 76,031,595 | RGD:2290271 | UniProtKB | ||
| G | GAP43 | growth associated protein 43 |
|
TAS | 3 | 115,342,151 | 115,440,334 | RGD:2290271 | PINC | ||
| G | GRM5 | glutamate receptor, metabotropic 5 |
|
IEA | 11 | 88,237,744 | 88,796,816 | RGD:2290271 | ENSEMBL | ||
| G | HCRT | hypocretin (orexin) neuropeptide precursor |
|
IEA | 17 | 40,336,078 | 40,337,470 | RGD:2290271 | ENSEMBL | ||
| G | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
IEA | 6 | 78,171,948 | 78,173,120 | RGD:2290271 | ENSEMBL | ||
| G | HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
ISS | 2 | 231,972,947 | 231,989,824 | RGD:2290271 | UniProtKB | ||
| G | IL2 | interleukin 2 |
|
IEA | 4 | 123,372,625 | 123,377,650 | RGD:2290271 | ENSEMBL | ||
| G | MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 |
|
IEA | 11 | 59,856,137 | 59,865,940 | RGD:2290271 | ENSEMBL | ||
| G | PARD3 | par-3 partitioning defective 3 homolog (C. elegans) |
|
TAS | 10 | 34,398,488 | 35,104,253 | RGD:2290271 | UniProtKB | ||
| G | PICK1 | protein interacting with PRKCA 1 |
|
IDA | 22 | 38,453,262 | 38,471,708 | RGD:2290271 | UniProtKB | ||
| G | PLCE1 | phospholipase C, epsilon 1 |
|
NAS | 10 | 95,753,746 | 96,088,149 | RGD:2290271 | UniProtKB | ||
| G | PPAP2A | phosphatidic acid phosphatase type 2A |
|
TAS | 5 | 54,720,682 | 54,830,873 | RGD:2290271 | UniProtKB | ||
| G | PRKD3 | protein kinase D3 |
|
TAS | 2 | 37,477,645 | 37,544,222 | RGD:2290271 | PINC | ||
| G | SPHK1 | sphingosine kinase 1 |
|
IEA | 17 | 74,380,690 | 74,383,941 | RGD:2290271 | InterPro | ||
| G | SPHK2 | sphingosine kinase 2 |
|
IEA | 19 | 49,122,548 | 49,133,663 | RGD:2290271 | InterPro | ||
regulation of adrenergic receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | RGS2 | regulator of G-protein signaling 2, 24kDa |
|
ISS | 1 | 192,778,169 | 192,781,407 | RGD:2290271 | BHF-UCL | ||
regulation of dopamine receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | DTNBP1 | dystrobrevin binding protein 1 |
|
ISS | 6 | 15,523,032 | 15,663,289 | RGD:2290271 | UniProtKB | ||
regulation of endocannabinoid signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABHD6 | abhydrolase domain containing 6 |
|
IEA | 3 | 58,223,259 | 58,280,461 | RGD:2290271 | ENSEMBL | ||
| G | MGLL | monoglyceride lipase |
|
ISS | 3 | 127,407,905 | 127,542,093 | RGD:2290271 | UniProtKB | ||
| G | MGLL | monoglyceride lipase |
|
IEA | 3 | 127,407,905 | 127,542,093 | RGD:2290271 | ENSEMBL | ||
regulation of G-protein coupled receptor protein signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) |
|
IDA | 18 | 904,944 | 912,173 | RGD:2290271 | UniProtKB | ||
| G | ARRB2 | arrestin, beta 2 |
|
IEA | 17 | 4,613,789 | 4,624,795 | RGD:2290271 | ENSEMBL | ||
| G | ARRB2 | arrestin, beta 2 |
|
IEA | 17 | 4,613,789 | 4,624,795 | RGD:2290271 | ENSEMBL | ||
| G | DYNLT1 | dynein, light chain, Tctex-type 1 |
|
ISS | 6 | 159,057,506 | 159,065,804 | RGD:2290271 | UniProtKB | ||
| G | GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 |
|
TAS | 17 | 27,900,487 | 27,916,610 | RGD:2290271 | PINC | ||
| G | GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 |
|
TAS | 12 | 110,367,607 | 110,434,194 | RGD:2290271 | PINC | ||
| G | GNG4 | guanine nucleotide binding protein (G protein), gamma 4 |
|
TAS | 1 | 235,710,985 | 235,814,054 | RGD:2290271 | PINC | ||
| G | GNG7 | guanine nucleotide binding protein (G protein), gamma 7 |
|
TAS | 19 | 2,511,218 | 2,702,746 | RGD:2290271 | PINC | ||
| G | GPR158 | G protein-coupled receptor 158 |
|
IEA | 10 | 25,464,290 | 25,891,158 | RGD:2290271 | ENSEMBL | ||
| G | GPSM1 | G-protein signaling modulator 1 |
|
IEA | 9 | 139,221,932 | 139,254,057 | RGD:2290271 | InterPro | ||
| G | GPSM2 | G-protein signaling modulator 2 |
|
IEA | 1 | 109,419,603 | 109,473,044 | RGD:2290271 | InterPro | ||
| G | GPSM3 | G-protein signaling modulator 3 |
|
IEA | 6 | 32,158,543 | 32,163,300 | RGD:2290271 | InterPro | ||
| G | GRK1 | G protein-coupled receptor kinase 1 |
|
TAS | 13 13 |
114,426,046 114,321,594 |
114,438,637 114,325,974 |
RGD:2290271 | PINC | ||
| G | GRK4 | G protein-coupled receptor kinase 4 |
|
TAS | 4 | 2,965,343 | 3,042,474 | RGD:2290271 | PINC | ||
| G | GRK5 | G protein-coupled receptor kinase 5 |
|
TAS | 10 | 120,967,197 | 121,215,131 | RGD:2290271 | PINC | ||
| G | GRK6 | G protein-coupled receptor kinase 6 |
|
TAS | 5 | 176,853,687 | 176,869,850 | RGD:2290271 | PINC | ||
| G | HOMER2 | homer homolog 2 (Drosophila) |
|
IEA | 15 | 83,517,729 | 83,621,476 | RGD:2290271 | ENSEMBL | ||
| G | ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
|
IEA | 10 | 33,189,246 | 33,247,293 | RGD:2290271 | ENSEMBL | ||
| G | KCTD12 | potassium channel tetramerisation domain containing 12 |
|
IEA | 13 | 77,454,304 | 77,460,540 | RGD:2290271 | ENSEMBL | ||
| G | KCTD16 | potassium channel tetramerisation domain containing 16 |
|
IEA | 5 | 143,550,437 | 143,856,944 | RGD:2290271 | ENSEMBL | ||
| G | KCTD8 | potassium channel tetramerisation domain containing 8 |
|
IEA | 4 | 44,175,920 | 44,450,824 | RGD:2290271 | ENSEMBL | ||
| G | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) |
|
ISS | 20 | 8,113,296 | 8,865,547 | RGD:2290271 | BHF-UCL | ||
| G | PLCE1 | phospholipase C, epsilon 1 |
|
IDA | 10 | 95,753,746 | 96,088,149 | RGD:2290271 | UniProtKB | ||
| G | RAMP1 | receptor (G protein-coupled) activity modifying protein 1 |
|
IEA | 2 | 238,768,187 | 238,820,756 | RGD:2290271 | InterPro | ||
| G | RAMP1 | receptor (G protein-coupled) activity modifying protein 1 |
|
IDA | 2 | 238,768,187 | 238,820,756 | RGD:2290271 | UniProtKB | ||
| G | RAMP2 | receptor (G protein-coupled) activity modifying protein 2 |
|
IEA | 17 | 40,913,212 | 40,915,059 | RGD:2290271 | InterPro | ||
| G | RAMP3 | receptor (G protein-coupled) activity modifying protein 3 |
|
IEA | 7 | 45,197,367 | 45,223,849 | RGD:2290271 | InterPro | ||
| G | RASGRP4 | RAS guanyl releasing protein 4 |
|
NAS | 19 | 38,899,698 | 38,916,945 | RGD:2290271 | UniProtKB | ||
| G | RGS11 | regulator of G-protein signaling 11 |
|
TAS | 16 | 318,310 | 325,914 | RGD:2290271 | PINC | ||
| G | RGS12 | regulator of G-protein signaling 12 |
|
TAS | 4 | 3,315,874 | 3,441,640 | RGD:2290271 | PINC | ||
| G | RGS14 | regulator of G-protein signaling 14 |
|
TAS | 5 | 176,784,844 | 176,799,599 | RGD:2290271 | PINC | ||
| G | RGS16 | regulator of G-protein signaling 16 |
|
TAS | 1 | 182,567,758 | 182,573,548 | RGD:2290271 | PINC | ||
| G | RGS2 | regulator of G-protein signaling 2, 24kDa |
|
TAS | 1 | 192,778,169 | 192,781,407 | RGD:2290271 | PINC | ||
| G | RGS20 | regulator of G-protein signaling 20 |
|
TAS | 8 | 54,764,368 | 54,871,863 | RGD:2290271 | PINC | ||
| G | RGS3 | regulator of G-protein signaling 3 |
|
TAS | 9 | 116,207,011 | 116,360,018 | RGD:2290271 | PINC | ||
| G | RGS4 | regulator of G-protein signaling 4 |
|
TAS | 1 | 163,038,396 | 163,046,592 | RGD:2290271 | PINC | ||
| G | RGS5 | regulator of G-protein signaling 5 |
|
TAS | 1 | 163,112,089 | 163,291,581 | RGD:2290271 | PINC | ||
| G | RGS6 | regulator of G-protein signaling 6 |
|
NAS | 14 | 72,398,817 | 73,033,238 | RGD:2290271 | UniProtKB | ||
| G | RGS7 | regulator of G-protein signaling 7 |
|
NAS | 1 | 240,938,817 | 241,520,478 | RGD:2290271 | UniProtKB | ||
| G | RGS9 | regulator of G-protein signaling 9 |
|
TAS | 17 | 63,133,456 | 63,223,821 | RGD:2290271 | PINC | ||
| G | RIC8B | resistance to inhibitors of cholinesterase 8 homolog B (C. elegans) |
|
IDA | 12 | 107,168,399 | 107,283,094 | RGD:2290271 | MGI | ||
| G | TULP3 | tubby like protein 3 |
|
IDA | 12 | 3,000,033 | 3,050,306 | RGD:2290271 | UniProtKB | ||
| G | USP20 | ubiquitin specific peptidase 20 |
|
IMP | 9 | 132,597,696 | 132,644,107 | RGD:2290271 | UniProtKB | ||
| G | USP33 | ubiquitin specific peptidase 33 |
|
IMP | 1 | 78,161,672 | 78,225,564 | RGD:2290271 | UniProtKB | ||
| G | USP33 | ubiquitin specific peptidase 33 |
|
IMP | 1 | 78,161,672 | 78,225,564 | RGD:2290271 | UniProtKB | ||
regulation of opioid receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | PPP1R9B | protein phosphatase 1, regulatory subunit 9B |
|
ISS | 17 | 48,211,101 | 48,227,877 | RGD:2290271 | UniProtKB | ||
| G | SYP | synaptophysin |
|
ISS | X | 49,044,265 | 49,056,661 | RGD:2290271 | UniProtKB | ||
| G | SYP | synaptophysin |
|
IEA | X | 49,044,265 | 49,056,661 | RGD:2290271 | ENSEMBL | ||
regulation of proteinase activated receptor activity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BICD1 | bicaudal D homolog 1 (Drosophila) |
|
ISS | 12 | 32,260,185 | 32,531,141 | RGD:2290271 | BHF-UCL | ||
regulation of rhodopsin mediated signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GRK1 | G protein-coupled receptor kinase 1 |
|
IDA | 13 13 |
114,426,046 114,321,594 |
114,438,637 114,325,974 |
RGD:2290271 | UniProtKB | ||
rhodopsin mediated signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GNAT1 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
|
IEA | 3 | 50,229,043 | 50,235,129 | RGD:2290271 | ENSEMBL | ||
| G | GRK1 | G protein-coupled receptor kinase 1 |
|
TAS | 13 13 |
114,426,046 114,321,594 |
114,438,637 114,325,974 |
RGD:2290271 | PINC | ||
| G | GRK1 | G protein-coupled receptor kinase 1 |
|
TAS | 13 13 |
114,426,046 114,321,594 |
114,438,637 114,325,974 |
RGD:2290271 | PINC | ||
| G | RHO | rhodopsin |
|
IEA | 3 | 129,247,482 | 129,254,187 | RGD:2290271 | ENSEMBL | ||
| G | SAG | S-antigen; retina and pineal gland (arrestin) |
|
TAS | 2 | 234,216,309 | 234,255,701 | RGD:2290271 | PINC | ||
| G | SAG | S-antigen; retina and pineal gland (arrestin) |
|
TAS | 2 | 234,216,309 | 234,255,701 | RGD:2290271 | PINC | ||
serotonin receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
TAS | 5 | 63,255,875 | 63,258,119 | RGD:2290271 | GOC | ||
| G | HTR1E | 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
|
IDA | 6 | 87,647,024 | 87,726,397 | RGD:2290271 | GOC | ||
| G | HTR1F | 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
|
IDA | 3 | 88,031,726 | 88,042,919 | RGD:2290271 | GOC | ||
| G | HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
IMP | 13 | 47,405,677 | 47,471,211 | RGD:2290271 | UniProtKB | ||
| G | HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
IMP | 2 | 231,972,947 | 231,989,824 | RGD:2290271 | UniProtKB | ||
| G | HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
IMP | X | 113,818,551 | 114,144,624 | RGD:2290271 | UniProtKB | ||
| G | HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
IDA | 11 | 113,845,797 | 113,861,035 | RGD:2290271 | GOC | ||
| G | HTR3A | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
NAS | 11 | 113,845,797 | 113,861,035 | RGD:2290271 | GOC | ||
| G | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
IDA | 5 | 147,830,595 | 148,033,739 | RGD:2290271 | GOC | ||
| G | HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
TAS | 5 | 147,830,595 | 148,033,739 | RGD:2290271 | GOC | ||
| G | HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
IDA | 7 | 154,862,034 | 154,879,102 | RGD:2290271 | GOC | ||
| G | HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
TAS | 10 | 92,500,575 | 92,617,671 | RGD:2290271 | GOC | ||
tachykinin receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRBK1 | adrenergic, beta, receptor kinase 1 |
|
IDA | 11 | 67,033,905 | 67,054,029 | RGD:2290271 | BHF-UCL | ||
| G | GRK5 | G protein-coupled receptor kinase 5 |
|
IDA | 10 | 120,967,197 | 121,215,131 | RGD:2290271 | BHF-UCL | ||
| G | TAC1 | tachykinin, precursor 1 |
|
IEA | 7 | 97,361,271 | 97,369,784 | RGD:2290271 | InterPro | ||
| G | TAC3 | tachykinin 3 |
|
IEA | 12 | 57,403,781 | 57,410,344 | RGD:2290271 | InterPro | ||
| G | TAC4 | tachykinin 4 (hemokinin) |
|
IEA | 17 | 47,915,671 | 47,925,379 | RGD:2290271 | ENSEMBL | ||
| G | TACR1 | tachykinin receptor 1 |
|
IDA | 2 | 75,273,590 | 75,426,645 | RGD:2290271 | BHF-UCL | ||
| G | TACR2 | tachykinin receptor 2 |
|
TAS | 10 | 71,163,958 | 71,176,674 | RGD:2290271 | PINC | ||
| G | TACR3 | tachykinin receptor 3 |
|
TAS | 4 | 104,510,625 | 104,640,973 | RGD:2290271 | PINC | ||
termination of G-protein coupled receptor signaling pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADRBK1 | adrenergic, beta, receptor kinase 1 |
|
IEA | 11 | 67,033,905 | 67,054,029 | RGD:2290271 | InterPro | ||
| G | ADRBK2 | adrenergic, beta, receptor kinase 2 |
|
IEA | 22 | 25,960,861 | 26,125,259 | RGD:2290271 | InterPro | ||
| G | AKAP10 | A kinase (PRKA) anchor protein 10 |
|
IEA | 17 | 19,807,765 | 19,881,169 | RGD:2290271 | InterPro | ||
| G | ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 |
|
IEA | 19 | 42,387,267 | 42,411,604 | RGD:2290271 | InterPro | ||
| G | ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 |
|
IEA | 1 | 156,904,632 | 157,015,162 | RGD:2290271 | InterPro | ||
| G | ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 |
|
IEA | 11 | 120,207,618 | 120,360,645 | RGD:2290271 | InterPro | ||
| G | AXIN1 | axin 1 |
|
IEA | 16 | 337,440 | 402,676 | RGD:2290271 | InterPro | ||
| G | AXIN2 | axin 2 |
|
IEA | 17 | 63,524,681 | 63,557,740 | RGD:2290271 | InterPro | ||
| G | GRK1 | G protein-coupled receptor kinase 1 |
|
IEA | 13 13 |
114,426,046 114,321,594 |
114,438,637 114,325,974 |
RGD:2290271 | InterPro | ||
| G | GRK4 | G protein-coupled receptor kinase 4 |
|
IEA | 4 | 2,965,343 | 3,042,474 | RGD:2290271 | InterPro | ||
| G | GRK5 | G protein-coupled receptor kinase 5 |
|
IEA | 10 | 120,967,197 | 121,215,131 | RGD:2290271 | InterPro | ||
| G | GRK6 | G protein-coupled receptor kinase 6 |
|
IEA | 5 | 176,853,687 | 176,869,850 | RGD:2290271 | InterPro | ||
| G | GRK7 | G protein-coupled receptor kinase 7 |
|
IEA | 3 | 141,497,043 | 141,535,892 | RGD:2290271 | InterPro | ||
| G | MYH9 | myosin, heavy chain 9, non-muscle |
|
IEA | 22 | 36,677,323 | 36,784,063 | RGD:2290271 | InterPro | ||
| G | RGS1 | regulator of G-protein signaling 1 | |||||||||




browse the term